This is a non-core endpoint: only basic statistics are computed.
Leiomyoma of uterus
CD2_BENIGN_LEIOMYOMA_UTERI_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly females |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpointsNone |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D10-D36
- Name in latin
- Leiomyoma uteri
Similar endpoints
↥List of similar endpoints to
Leiomyoma of uterus
based on the number of shared cases.
Similar with more cases:
- Leiomyoma of uterus
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 43521 | 43521 | - |
| Unadjusted period prevalence (%) | 14.83 | 14.83 | - |
| Median age at first event (years) | 46.68 | 46.68 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 6468
- Matched controls
- 46868
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
LCD04
NOMESCO Finland
Laparoscopic hysterectomy
10.7
323.0
758
576
LCB14
NOMESCO Finland
Laparoscopic myolysis
99.3
323.0
447
35
LCD00
NOMESCO Finland
Hysterectomy
23.2
323.0
533
181
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
3.3
323.0
4097
16262
D25.1
ICD-10 Finland
Intramural leiomyoma of uterus
133.5
323.0
2229
184
LCD01
NOMESCO Finland
Total laparoscopic hysterectomy
11.7
323.0
773
537
D25.0
ICD-10 Finland
Submucous leiomyoma of uterus
365.0
323.0
1611
43
LCA06
NOMESCO Finland
Biopsy of endometrium
5.9
323.0
2356
4154
B02AA02
ATC
tranexamic acid; systemic
3.8
323.0
2261
5793
D25.2
ICD-10 Finland
Subserosal leiomyoma of uterus
165.8
323.0
923
47
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
4.0
323.0
2099
5038
D25.9
ICD-10 Finland
Leiomyoma of uterus, unspecified
323.0
323.0
4077
246
LBE20
NOMESCO Finland
Laparoscopic bilateral salpingectomy
13.5
323.0
736
440
G03XB02
ATC
ulipristal; oral (progesterone receptor modulators)
243.4
252.9
291
9
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
3.6
228.1
1245
2905
D25
ICD-10 Finland
Leiomyoma of uterus
18.5
220.5
379
157
115
Kela drug reimbursment
Breast cancer
+∞
218.8
237
*
LCB10
NOMESCO Finland
Myomectomy
146.7
212.8
253
13
LCB11
NOMESCO Finland
Laparoscopic myomectomy
341.1
201.0
228
5
LBE01
NOMESCO Finland
Laparoscopic salpingectomy
4.8
184.7
705
1161
TLC00
NOMESCO Finland
Insertion of intrauterine device
2.8
171.1
1408
4298
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
3.5
169.8
938
2166
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
4.7
162.4
630
1050
PJA12
NOMESCO Finland
Sentinel node biopsy
87.9
160.5
200
17
WX402
NOMESCO Finland
General anaesthesia
2.8
158.7
1253
3706
LC2DE
NOMESCO Finland
Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods
3.7
158.5
810
1749
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.4
151.4
1586
5499
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
141.8
154
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.4
136.8
1458
5061
LCD97
NOMESCO Finland
Other laparoscopic hysterectomy
134.6
136.1
163
9
N84.0
ICD-10 Finland
Polyp of corpus uteri
3.6
129.6
684
1504
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
126.1
137
*
H02AB02
ATC
dexamethasone; systemic
9.5
116.0
265
210
L02BA01
ATC
tamoxifen; oral
34.4
112.2
162
35
21899
ICD-8 Finland
Uterine fibroma
+∞
107.6
117
*
A04AA55
ATC
palonosetron, combinations; systemic
441.9
106.6
120
*
O34.1
ICD-10 Finland
Maternal care for tumour of corpus uteri
12.4
105.4
210
126
N02BE01
ATC
paracetamol; systemic, rectal
2.0
102.9
5344
32915
B01AB05
ATC
enoxaparin; parenteral
2.1
102.6
1420
5473
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
177.1
102.3
120
5
LBE00
NOMESCO Finland
Salpingectomy
11.0
98.3
207
140
LCD10
NOMESCO Finland
Vaginal hysterectomy
5.2
96.6
336
490
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
266.3
95.0
109
*
A04AA02
ATC
granisetron; systemic, transdermal
51.3
93.5
125
18
WX302
NOMESCO Finland
Thoracal epidural anesthesy
5.7
90.1
290
385
L03AA13
ATC
pegfilgrastim; parenteral
727.7
89.0
99
*
HAC20
NOMESCO Finland
Total mastectomy
75.8
81.4
103
10
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
79.9
87
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
77.4
713
2231
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
322.0
77.4
88
*
B01AB10
ATC
tinzaparin; parenteral
4.3
76.6
316
551
ULC02
NOMESCO Finland
Hysteroscopy
2.8
73.3
541
1485
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
0.6
73.2
2066
20485
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
2.0
72.6
1112
4391
WX408
NOMESCO Finland
General anesthesy, balanced
1.8
72.2
1469
6438
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
3.9
71.9
333
647
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.6
69.8
2619
24481
N92.4
ICD-10 Finland
Excessive bleeding in the premenopausal period
3.1
69.4
421
1014
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
288.4
69.2
79
*
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
0.6
68.7
1176
13213
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
39.2
68.6
96
18
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
7.4
68.4
180
181
LBE10
NOMESCO Finland
Bilateral salpingectomy
59.5
68.2
89
11
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
5.5
65.4
214
290
130
Kela drug reimbursment
Malignant tumour
+∞
63.4
69
*
SPAT1197
SPAT
Extensive health check-up of expecting family
0.5
56.6
634
8063
TLC02
NOMESCO Finland
Simple extraction of IUD
2.2
56.3
634
2176
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
56.0
61
*
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
0.6
55.8
1115
12195
W78
ICPC
Pregnancy
0.5
55.2
758
9119
8500/3-C50.4
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast
+∞
55.1
60
*
2180A
ICD-9 Finland
Uterine leiomyoma, Submucous leiomyoma of uterus
+∞
55.1
60
*
N80.1
ICD-10 Finland
Endometriosis of ovary
2.5
53.4
481
1475
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
1.7
53.1
1297
5944
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
52.3
57
*
MAX99
NOMESCO Finland
Assistance to normal delivery
0.5
52.2
547
7110
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
9.1
51.8
119
96
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.7
51.3
1273
5853
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
2.4
51.2
500
1597
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.9
51.1
234
450
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
216.8
51.0
59
*
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.1
50.7
650
2358
HAB40
NOMESCO Finland
Wedge excision of mammary gland
13.5
49.5
94
51
C50
ICD-10 Finland
Malignant neoplasm of breast
209.2
49.2
57
*
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
48.6
53
*
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.6
47.9
1716
8696
D39.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Uterus
14.5
47.2
87
44
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
0.6
46.7
1143
12040
A04AD12
ATC
aprepitant; systemic
102.3
45.9
56
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
45.9
50
*
Z39.2
ICD-10 Finland
Routine postpartum follow-up
0.6
45.4
792
9031
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
45.0
49
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
45.0
49
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
69.4
44.8
57
6
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.4
44.2
177
300
L01BC06
ATC
capecitabine; oral
+∞
44.0
48
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
42.2
46
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
41.6
1989
10710
HA1AA
NOMESCO Finland
X-ray mammography
2.8
41.5
297
796
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
29.7
41.4
61
15
SPAT1196
SPAT
Monitoring of normal pregnancy
0.5
41.3
370
5069
LCB98
NOMESCO Finland
Other transluminal endoscopic excision of lesion of uterus
4.9
41.0
146
219
N92.6
ICD-10 Finland
Irregular menstruation, unspecified
1.8
39.9
792
3369
JN4BD
NOMESCO Finland
Extensive body CT
3.6
39.8
200
417
LDA00
NOMESCO Finland
Dilatation of cervix uteri
5.2
39.4
133
188
N80.0
ICD-10 Finland
Endometriosis of uterus
2.7
38.9
288
786
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
+∞
38.5
42
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
38.5
42
*
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
0.6
38.2
891
9562
X76
ICPC
Malignant neoplasm breast female
+∞
37.6
41
*
LCD11
NOMESCO Finland
Laparoscopically assisted vaginal hysterectomy
9.2
36.6
83
66
MA2JE
NOMESCO Finland
Ultrasound screening of fetal nuchal translucency
0.6
36.1
481
5910
SPAT1380
SPAT
Postpartum check-up
0.5
35.8
392
5083
JN4AD
NOMESCO Finland
Body CT examination
4.9
35.7
126
188
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
49.1
35.3
47
7
Z30.4
ICD-10 Finland
Surveillance of contraceptive drugs
0.4
35.2
199
3184
128
Kela drug reimbursment
Cancers of female genital organs
102.1
34.5
42
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
47.9
34.4
46
7
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
2.4
34.4
324
1015
SPAT1379
SPAT
Health check-up of pregnant person
0.6
34.3
501
6015
WX704
NOMESCO Finland
Intubation
2.1
34.1
423
1504
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
7.4
33.8
87
86
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
3.4
33.7
179
391
P01AB01
ATC
metronidazole; oral, rectal
1.4
33.2
2675
15751
SPAT1308
SPAT
Sexual health counselling
0.6
33.0
692
7637
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
33.0
36
*
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
17.8
33.0
56
23
L03AA02
ATC
filgrastim; parenteral
22.3
32.9
52
17
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
52.3
32.6
43
6
WX307
NOMESCO Finland
Obstetric epidural analgesia
0.5
32.6
382
4867
PD2DT
NOMESCO Finland
Embolisation of gynekological tumor
260.9
31.5
36
*
X78
ICPC
Fibromyoma uterus
35.6
31.2
44
9
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
43.7
31.0
42
7
LAF01
NOMESCO Finland
Laparoscopic unilateral salpingo-oophorectomy
2.5
30.9
257
753
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
30.8
1360
7109
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
25.3
29.5
45
13
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
29.3
32
*
WX321
NOMESCO Finland
Acute spinal anesthesia for delivery
0.4
29.2
151
2496
M01AE01
ATC
ibuprofen; systemic, rectal
1.6
28.7
5903
40521
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
26.1
28.5
43
12
C50.51
ICD-10 Finland
Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor
+∞
27.5
30
*
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
4.3
27.5
109
185
ZX080
NOMESCO Finland
Image guided radiotherapy
31.6
27.0
39
9
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
227.2
27.0
31
*
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.0
26.8
163
394
XX3DW
NOMESCO Finland
Time consuming IT work
2.4
26.7
236
716
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
51.0
26.6
35
5
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
5.8
26.5
81
103
LCA10
NOMESCO Finland
Curettage of body of uterus
2.5
26.2
229
690
W11
ICPC
Contraception oral
0.5
26.1
304
3891
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.9
25.9
437
1751
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
+∞
25.7
28
*
HA1DG
NOMESCO Finland
Very extensive MRI examination of mammary gland with high intensity magnet
10.0
25.7
55
40
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
2.6
25.5
205
591
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
25.4
845
4123
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
25.2
232
718
TQW20
NOMESCO Finland
Tatoe
18.0
25.0
42
17
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
41.3
24.9
34
6
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
24.8
27
*
W12
ICPC
Contraception intrauterine
0.7
23.9
689
7168
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.9
23.9
156
397
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
23.8
26
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
23.8
26
*
Z37.0
ICD-10 Finland
Single live birth
0.7
23.8
758
7742
N95.1
ICD-10 Finland
Menopausal and female climacteric states
1.5
23.5
851
4230
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
23.4
160
419
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
5.6
23.3
73
96
1CD02
NOMESCO Finland
NA
+∞
22.9
25
*
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
2.8
22.7
153
397
O81.4
ICD-10 Finland
Vacuum extractor delivery
0.6
22.0
373
4351
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
22.0
329
1263
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
0.7
21.4
851
8379
SPAT1190
SPAT
Insertion or removal of intrauterine contraceptive device
0.6
21.4
365
4255
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
94.6
21.4
26
*
N02AX02
ATC
tramadol; systemic, rectal
1.3
21.1
1808
10532
L02BG06
ATC
exemestane; oral
+∞
21.1
23
*
C54.11
ICD-10 Finland
Adenocarcinoma of the endometrium
+∞
21.1
23
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
21.1
23
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
21.1
23
*
ZXC40
NOMESCO Finland
Use of ultrasound
6.1
21.0
61
73
C08CA01
ATC
amlodipine; oral
1.6
20.3
663
3213
W90
ICPC
Uncompl labour/delivery livebirth
0.5
20.3
148
2179
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
+∞
20.2
22
*
N93.9
ICD-10 Finland
Abnormal uterine and vaginal bleeding, unspecified
2.2
19.7
213
715
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
3.6
19.7
96
198
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
4.4
19.7
76
127
NK6AN
NOMESCO Finland
Total body bone isotope imaging
19.4
19.7
32
12
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
19.3
21
*
MAE00
NOMESCO Finland
Outlet vacuum delivery
0.6
19.1
307
3631
ZXA10
NOMESCO Finland
Bilateral
1.5
19.0
702
3496
A02BC02
ATC
pantoprazole; systemic
1.3
19.0
3220
20513
S18
ICPC
Laceration/cut
1.3
18.7
1503
8639
Z34
ICD-10 Finland
Supervision of normal pregnancy
0.5
18.7
197
2595
D44.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Thyroid gland
4.0
18.5
78
142
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.1
18.5
224
789
X06
ICPC
Menstruation excessive
2.2
18.4
189
619
6500B
ICD-9 Finland
Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]
1.4
18.3
1049
5700
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.1
18.3
104
242
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.2
18.3
43
38
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
18.1
1564
9080
LCB20
NOMESCO Finland
Transvaginal myomectomy
36.4
18.0
25
5
ZX070
NOMESCO Finland
Intensity modified radiotherapy
152.6
18.0
21
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.8
17.9
319
1303
SPAT1153
SPAT
Removal of sutures
1.4
17.8
1118
6171
WX702
NOMESCO Finland
Supraglottic ventilation device
1.9
17.7
262
1001
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
17.4
19
*
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
+∞
17.4
19
*
Z30.1
ICD-10 Finland
Insertion of (intrauterine) contraceptive device
0.7
16.9
1026
9504
N93.8
ICD-10 Finland
Other specified abnormal uterine and vaginal bleeding
2.3
16.9
161
511
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
16.5
18
*
8500/3-C50.2
ICD-O-3
Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast
+∞
16.5
18
*
N921, D250
ICD-10 Finland
NA
+∞
16.5
18
*
N920, D259
ICD-10 Finland
NA
+∞
16.5
18
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
16.4
215
785
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
0.7
16.2
772
7420
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
138.0
16.2
19
*
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
138.0
16.2
19
*
JAH01
NOMESCO Finland
Laparoscopy
1.7
16.2
378
1679
A04AA01
ATC
ondansetron; systemic, rectal
2.2
16.1
180
615
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
72.7
16.1
20
*
JN3AD
NOMESCO Finland
Abdominal CT examination
1.9
16.0
246
955
LBF01
NOMESCO Finland
Laparoscopic perfusion of Fallopian tube
2.0
16.0
222
829
A03FA01
ATC
metoclopramide; systemic, rectal
1.4
15.9
864
4640
TMA00
NOMESCO Finland
Episiotomy
0.5
15.7
154
2074
L02AE02
ATC
leuprorelin; implant, parenteral
2.2
15.7
175
598
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
15.6
17
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
15.6
17
*
JN5PN
NOMESCO Finland
Isotope imaging of secondary neoplasms of thyroid origin
+∞
15.6
17
*
L02AE03
ATC
goserelin; implant
3.4
15.5
79
171
JN4CD
NOMESCO Finland
Very extensive body CT
5.1
15.4
51
73
N97.8
ICD-10 Finland
Female infertility of other origin
1.9
15.4
243
953
ZXC96
NOMESCO Finland
Robot assisted procedure
5.0
15.3
51
74
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
4.4
15.2
58
97
C50.11
ICD-10 Finland
Malignant tumor of the central part of the mammary gland,ductal tumor
69.0
15.2
19
*
LDB00
NOMESCO Finland
Excision of lesion of cervix uteri
2.7
15.1
104
277
WZC30
NOMESCO Finland
Teaching
1.6
14.9
383
1746
C73
ICD-10 Finland
Malignant neoplasm of thyroid gland
+∞
14.7
16
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
14.7
16
*
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
6.2
14.6
41
48
G03DC03
ATC
lynestrenol; oral
1.9
14.5
215
824
O99.80
ICD-10 Finland
The fear of childbirth
0.6
14.5
282
3199
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
0.7
14.5
534
5356
WX110
NOMESCO Finland
Local anesthesy
1.2
14.4
4186
27954
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
14.3
1296
7538
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
+∞
13.7
15
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.7
15
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
43.6
13.5
18
*
N94.5
ICD-10 Finland
Secondary dysmenorrhoea
1.9
13.5
216
851
WX720
NOMESCO Finland
Own respiration
2.1
13.5
161
566
JAL21
NOMESCO Finland
Laparoscopic excision or destruction of lesion of peritoneum
2.0
13.5
174
634
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
17.8
13.3
22
9
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
3.9
13.1
56
105
LCC10
NOMESCO Finland
Supravaginal hysterectomy
8.8
13.0
29
24
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.1
12.9
33
34
8500/3-C50.5
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast
+∞
12.8
14
*
8380/3-C54.1
ICD-O-3
Endometrioid adenocarcinoma, NOS, of endometrium
+∞
12.8
14
*
LAE11
NOMESCO Finland
Unilateral laparoscopic oophorectomy
3.7
12.8
58
115
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.6
12.8
317
1432
UJF32
NOMESCO Finland
Coloscopy
1.4
12.7
803
4416
N80.9
ICD-10 Finland
Endometriosis, unspecified
1.8
12.7
240
1001
D39.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified
8.4
12.7
29
25
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
5.0
12.7
42
61
I97.2
ICD-10 Finland
Postmastectomy lymphoedema syndrome
58.1
12.6
16
*
BAA40
NOMESCO Finland
Unilateral lobectomy of thyroid gland
2.3
12.5
116
366
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
0.7
12.4
630
6016
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
12.3
482
2424
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.7
12.3
252
1077
O80.8
ICD-10 Finland
Other single spontaneous delivery
0.6
12.2
220
2540
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
8.9
12.2
27
22
N70.1
ICD-10 Finland
Chronic salpingitis and oophoritis
2.4
12.2
103
309
N73.6
ICD-10 Finland
Female pelvic peritoneal adhesions
2.5
12.1
100
298
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
11.9
13
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
11.9
13
*
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
+∞
11.9
13
*
R93.5
ICD-10 Finland
Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum
3.1
11.9
67
157
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
11.9
224
936
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
6.2
11.8
33
39
XX7CT
NOMESCO Finland
Radioiodine therapy of thydoid tissue
5.3
11.8
37
51
O68.0
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly
0.7
11.8
326
3445
8302
FHL
Tumor removal (e.g., enucleation) or polyp removal
21.8
11.7
18
6
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
0.7
11.6
681
6371
C09CA01
ATC
losartan; oral
1.4
11.6
523
2708
W14
ICPC
Contraception female other
0.6
11.5
187
2208
XMA22
NOMESCO Finland
General examination of pregnant woman
0.7
11.5
497
4864
A02BC05
ATC
esomeprazole; systemic
1.2
11.4
1910
11922
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
10.4
11.4
23
16
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.2
11.3
2207
13998
SPAT1193
SPAT
Pap smear
0.8
11.2
694
6452
G03DA02
ATC
medroxyprogesterone; systemic (pregnen (4) derivatives)
1.6
11.1
265
1186
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
11.0
12
*
WB402
NOMESCO Finland
Demanding antibody therapy of primary tumour
+∞
11.0
12
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
11.0
12
*
8500/3-C50.8
ICD-O-3
Infiltrating duct carcinoma, NOS, of overlapping lesion of breast
+∞
11.0
12
*
XX1XN
NOMESCO Finland
Other isotope examination
36.3
11.0
15
*
SPAT1200
SPAT
Guidance for breast-feeding and breast care
0.5
10.9
88
1253
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
0.8
10.8
694
6425
N84.1
ICD-10 Finland
Polyp of cervix uteri
2.0
10.8
149
557
SPAT1357
SPAT
Monitoring of problem during pregnancy
0.6
10.8
132
1670
N80.4
ICD-10 Finland
Endometriosis of rectovaginal septum and vagina
1.9
10.8
157
601
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
5.0
10.7
35
51
TQW99
NOMESCO Finland
Other minor procedure on skin
2.1
10.5
115
394
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
5.4
10.5
32
43
N92.5
ICD-10 Finland
Other specified irregular menstruation
1.5
10.4
324
1551
R2110
NOMESCO Finland
Giving the first information
1.4
10.4
516
2723
C07AB07
ATC
bisoprolol; oral
1.3
10.3
1238
7435
WF002
NOMESCO Finland
Radical radiotherapy
7.3
10.2
25
25
Z51.0
ICD-10 Finland
Radiotherapy session
33.9
10.2
14
*
XLA10
NOMESCO Finland
NA
1.5
10.1
383
1915
BAA60
NOMESCO Finland
Total thyroidectomy
2.1
10.1
121
430
C73.99
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology
+∞
10.1
11
*
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
+∞
10.1
11
*
D50
ICD-10 Finland
Iron deficiency anaemia
1.9
10.1
145
553
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
47.1
10.0
13
*
C43.72
ICD-10 Finland
Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type
87.1
9.9
12
*
Z51.5
ICD-10 Finland
Palliative care
5.2
9.9
31
43
SPAT1192
SPAT
Gynaecological examination
0.8
9.9
666
6128
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
2.4
9.9
83
251
8113
FHL
Fractional scraping
3.0
9.9
58
142
W85
ICPC
Gestational diabetes
0.6
9.8
180
2066
O48
ICD-10 Finland
Prolonged pregnancy
0.6
9.8
178
2047
HAB99
NOMESCO Finland
Other partial excision of mammary gland
2.7
9.8
66
177
M03BX02
ATC
tizanidine; oral
1.2
9.7
3931
26525
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.9
9.7
148
577
SPAT1317
SPAT
Planned health check-up monitoring, health check-up performed based on individual need
0.7
9.6
518
4910
Y60.0
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during surgical operation
5.0
9.6
31
45
N25.9
ICD-10 Finland
Disorder resulting from impaired renal tubular function, unspecified
25.4
9.6
14
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
25.4
9.6
14
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
25.4
9.6
14
*
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
0.7
9.5
282
2939
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.8
9.4
157
633
LAC21
NOMESCO Finland
Laparoscopic destruction of lesion of ovary
2.0
9.4
117
422
WX400
NOMESCO Finland
Inhalation anesthesy
1.6
9.2
264
1239
N97.9
ICD-10 Finland
Female infertility, unspecified
1.3
9.2
691
3899
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
9.2
10
*
C73.90
ICD-10 Finland
Malignant tumor of the thyroid gland (thyroid gland) without histology
+∞
9.2
10
*
C54.22
ICD-10 Finland
Endometrial stromal cell sarcoma
+∞
9.2
10
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
9.2
10
*
C56.73
ICD-10 Finland
Endomeroid epithelial carcinoma of the ovary
+∞
9.2
10
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
+∞
9.2
10
*
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
43.5
9.1
12
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.2
9.1
1847
11697
C09DA01
ATC
losartan and diuretics; oral
1.7
9.1
183
782
N85.0
ICD-10 Finland
Endometrial glandular hyperplasia
2.2
9.1
90
293
Z32.1
ICD-10 Finland
Pregnancy confirmed
0.8
9.1
764
6844
W84
ICPC
Pregnancy high risk
0.6
9.0
150
1759
WX002
NOMESCO Finland
Sedation and analgesia
1.3
9.0
598
3309
H01CA02
ATC
nafarelin; nasal
1.5
8.9
325
1613
HAE99
NOMESCO Finland
Other reconstruction of breast
6.2
8.9
24
28
N99.4
ICD-10 Finland
Postprocedural pelvic peritoneal adhesions
2.6
8.8
63
175
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.4
8.8
75
229
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
23.6
8.7
13
*
G03DA04
ATC
progesterone; systemic, rectal, vaginal
1.5
8.7
275
1324
L02BG04
ATC
letrozole; oral
1.7
8.6
188
824
LAA10
NOMESCO Finland
Percutaneous or transvaginal puncture and recovery of oocyte
1.5
8.6
263
1259
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
1.8
8.5
149
610
ZZR10
NOMESCO Finland
Flap of skin and muscle
13.6
8.5
15
8
ZXA00
NOMESCO Finland
Right side
1.3
8.4
753
4349
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
+∞
8.2
9
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
+∞
8.2
9
*
N920, D250
ICD-10 Finland
NA
+∞
8.2
9
*
C73.92
ICD-10 Finland
Follicular carcinoma of the thyroid gland
+∞
8.2
9
*
C54.21
ICD-10 Finland
Leiomyosarcoma and myometrium
+∞
8.2
9
*
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
8.2
9
*
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
8.2
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
8.2
9
*
C50.4
ICD-10 Finland
Malignant neoplasm: Upper-outer quadrant of breast
+∞
8.2
9
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
8.2
9
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
8.2
9
*
D50.8
ICD-10 Finland
Other iron deficiency anaemias
2.3
8.2
77
247
R4110
NOMESCO Finland
Physiotherapy
1.3
8.2
909
5393
SPAT1399
SPAT
Acceptance of acknowledgement of paternity of child born outside of marriage before the birth of the child at the maternity clinic. Paternity Act, Section 16.
0.6
8.2
127
1514
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
1.3
8.2
674
3850
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
2.7
8.2
56
152
SPAT1189
SPAT
Other ultrasound examination during pregnancy
0.6
8.2
124
1485
ZXA05
NOMESCO Finland
Left side
1.3
8.2
689
3951
KCH01
NOMESCO Finland
Percutaneous endoscopic suture of bladder
14.5
8.1
14
7
N92
ICD-10 Finland
Excessive, frequent and irregular menstruation
1.7
8.1
151
634
JAL30
NOMESCO Finland
Omentectomy
5.2
8.1
25
35
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.2
8.0
1011
6090
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.7
7.9
148
621
M01AB05
ATC
diclofenac; systemic, rectal
1.2
7.9
3798
25760
LEE00
NOMESCO Finland
Suture of vagina
5.9
7.9
22
27
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.8
7.9
122
482
A02BC03
ATC
lansoprazole; oral
1.2
7.9
1172
7188
R18
ICD-10 Finland
Ascites
4.4
7.8
28
46
O63.1
ICD-10 Finland
Prolonged second stage (of labour)
0.6
7.8
173
1908
ZZF00
NOMESCO Finland
Graft of adipose tissue
4.1
7.8
30
53
C10AA07
ATC
rosuvastatin; oral
1.4
7.8
364
1901
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
4.0
7.8
31
57
M01AH05
ATC
etoricoxib; oral
1.2
7.7
3229
21647
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
2.7
7.7
52
139
JAH00
NOMESCO Finland
Laparotomy
2.3
7.7
73
235
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
26.6
7.7
11
*
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
7.6
263
1293
WW500
NOMESCO Finland
Blood transfusion
1.9
7.6
110
425
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.4
7.6
413
2218
O70.1
ICD-10 Finland
Second degree perineal laceration during delivery
0.6
7.5
113
1354
N83.1
ICD-10 Finland
Corpus luteum cyst
1.8
7.5
135
561
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
7.3
7.5
18
18
UKC02
NOMESCO Finland
Cystoscopy
1.4
7.5
304
1549
N02AA05
ATC
oxycodone; systemic
1.5
7.5
238
1152
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
5.6
7.3
21
27
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
7.3
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
7.3
8
*
8091/3-C44.9
ICD-O-3
Superficial basal cell carcinoma of skin, NOS
+∞
7.3
8
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
7.3
8
*
N921, D259
ICD-10 Finland
NA
+∞
7.3
8
*
4CJ01
NOMESCO Finland
NA
+∞
7.3
8
*
9707
FHL
Ablation of mammae and removal of axillary lymph nodes
+∞
7.3
8
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
7.3
8
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
7.3
8
*
C50.22
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor
+∞
7.3
8
*
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
65.3
7.3
9
*
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
7.2
323
1673
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.5
7.2
57
169
XLD10
NOMESCO Finland
Gynaecological examination
2.9
7.1
42
106
N97.2
ICD-10 Finland
Female infertility of uterine origin
4.6
7.0
24
38
G03GA01
ATC
chorionic gonadotrophin; parenteral
1.3
7.0
495
2769
SPAT1195
SPAT
Antenatal classes
0.6
7.0
109
1296
ZZR00
NOMESCO Finland
Flap of skin
4.3
6.9
25
42
M01AE02
ATC
naproxen; oral, rectal
1.2
6.9
3344
22583
HAD99
NOMESCO Finland
Other plastic operation on breast
4.1
6.9
26
46
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
24.2
6.9
10
*
Z30.0
ICD-10 Finland
General counselling and advice on contraception
0.8
6.8
386
3636
N05CF02
ATC
zolpidem; oral
1.2
6.7
903
5471
G03GA06
ATC
follitropin beta; parenteral
1.4
6.7
336
1777
J01MA12
ATC
levofloxacin; systemic
1.3
6.7
544
3104
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
2.2
6.6
64
211
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
6.6
349
1864
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
32.6
6.6
9
*
HA6HA
NOMESCO Finland
Tomosynthesis assessment of mammary gland specimen
32.6
6.6
9
*
D27.91
ICD-10 Finland
Benign epithelial tumor of the ovary (ovary)
2.3
6.5
55
171
JAL01
NOMESCO Finland
Laparoscopic biopsy of peritoneum
4.8
6.4
21
32
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
58.1
6.4
8
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
58.1
6.4
8
*
C77.3
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes
+∞
6.4
7
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
+∞
6.4
7
*
C50.19
ICD-10 Finland
Malignant tumor of the central part of the mammary gland, other or undeterminated histology
+∞
6.4
7
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
6.4
7
*
1501
Kela drug reimbursment
Palbociclib
+∞
6.4
7
*
C50.20
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication
+∞
6.4
7
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.4
7
*
8500/3-C50.3
ICD-O-3
Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast
+∞
6.4
7
*
JN5AQ
NOMESCO Finland
SPECT of thyroid metastasis with low-dose CT
+∞
6.4
7
*
D37.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts
2.8
6.4
41
108
N80.5
ICD-10 Finland
Endometriosis of intestine
2.1
6.4
69
238
Z30.8
ICD-10 Finland
Other contraceptive management
0.6
6.4
80
1001
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
18.1
6.4
10
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.1
6.4
71
249
LAC00
NOMESCO Finland
Excision of ovarian cyst
3.0
6.3
36
88
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
6.3
1722
11131
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.9
6.2
87
333
LGA21
NOMESCO Finland
Laparoscopic sterilisation by constriction of Fallopian tubes
1.3
6.2
376
2054
D26.1
ICD-10 Finland
Other benign neoplasm: Corpus uteri
5.9
6.2
17
21
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
5.9
6.2
17
21
N94.6
ICD-10 Finland
Dysmenorrhoea, unspecified
1.6
6.2
159
732
E04.2
ICD-10 Finland
Nontoxic multinodular goitre
1.6
6.1
139
619
ZX120
NOMESCO Finland
Intravenous
1.4
6.1
260
1336
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
6.1
164
763
SPAT1273
SPAT
Structured assessment of psychoactive substance / tobacco use
0.6
6.1
116
1316
Z71.8
ICD-10 Finland
Other specified counselling
1.2
6.1
1317
8347
PJA01
NOMESCO Finland
Laparoscopic sentinel node excision
21.8
6.1
9
*
LBF00
NOMESCO Finland
Perfusion of Fallopian tube
2.2
6.0
57
186
HA1CM
NOMESCO Finland
Mammary gland extensive MRI examination with 3 Tesla magnet
5.2
6.0
18
25
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
2.6
6.0
42
116
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044640) Blood type and Crossmatch panel - Blood
8172
29483
1.83
307.65
2.1
1.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2513
5102
2.97
307.65
3.3
1.6
ug/l
20.7
9.2
1.12
1890
3655
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
680
251
15.66
307.65
3.5
1.2
u/ml
37.1
26.5
0.54
654
227
(3002256) Pathology report gross observation
3958
10431
2.35
307.65
1.3
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
3106
6854
2.77
307.65
2.7
1.5
u/ml
40.5
25.5
5.32
3006
6564
(4035726)
2320
3375
4.16
307.65
1.4
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
11773
46623
1.79
307.65
3.7
3.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
12108
44827
2.00
307.65
2.2
1.7
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
284
34
47.58
298.18
1.0
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
973
1334
4.23
292.58
1.3
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
6125
21776
1.77
270.10
2.1
1.9
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
1516
3220
2.76
238.38
1.5
1.4
pmol/l
102.5
66.9
2.78
1483
3146
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
11905
51674
1.56
233.14
5.6
3.5
umol/l
10.0
10.1
0.73
11233
48163
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
282
132
12.16
198.70
6.2
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
17617
85337
1.54
189.72
7.2
5.3
u/l
76.2
74.1
10.54
16506
79739
(4281824)
549
734
4.28
169.50
1.1
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
188
69
15.46
147.77
1.1
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
8121
35091
1.45
137.99
3.2
2.0
mmol/l
2.4
2.4
9.15
7043
30367
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
10163
45801
1.42
137.10
5.4
4.5
mmol/l
1.2
1.2
4.59
9136
41129
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
11242
51683
1.41
134.59
6.1
5.0
mmol/l
1.2
1.2
2.09
9426
43803
(3032080) INR in Blood by Coagulation assay
8273
36193
1.43
129.37
7.0
6.7
inr
1.1
1.2
1.04
2467
10823
(3019550) Sodium [Moles/volume] in Serum or Plasma
22917
120923
1.74
129.27
13.9
11.3
mmol/l
139.8
139.8
0.11
22445
117733
(3023103) Potassium [Moles/volume] in Serum or Plasma
22976
121345
1.75
128.67
14.1
11.4
mmol/l
3.9
3.9
8.05
22472
117912
(3024561) Albumin [Mass/volume] in Serum or Plasma
9590
43382
1.40
121.96
4.1
3.6
g/l
36.2
36.4
4.31
8830
39852
(3013650) Neutrophils [#/volume] in Blood by Automated count
13095
62510
1.37
119.29
8.5
6.7
e9/l
4.0
4.0
2.71
11382
54566
(3031040) Bacteria [#/volume] in Urine by Automated count
15409
75794
1.37
114.01
4.6
4.2
e6/l
1438.7
2120.0
1.00
161
875
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
804
1847
2.50
107.46
1.2
1.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
253
250
5.75
107.00
1.1
1.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
12514
60079
1.34
103.13
4.0
3.7
mmol/l
6.5
6.5
0.14
11740
55306
(3023368) Bacteria identified in Blood by Culture
5063
21091
1.44
97.77
3.8
3.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
21275
111584
1.47
97.65
11.8
9.0
ml/min/173m2
82.8
83.7
8.48
17754
90117
(3013512) EKG study
6589
28864
1.39
95.32
3.6
3.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
182
141
7.32
94.21
1.2
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
5754
24883
1.39
88.67
3.4
3.2
%
98.2
96.6
5.28
5586
24036
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
22407
119479
1.51
82.77
13.0
10.4
mg/l
20.4
18.8
9.86
17818
90794
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
2059
7290
1.64
82.34
2.2
2.1
g/l
0.2
0.2
4.12
1940
6703
(3020564) Creatinine [Moles/volume] in Serum or Plasma
23540
127175
1.64
77.56
14.7
11.3
umol/l
68.4
68.5
0.25
23531
127101
(3012095) Magnesium [Moles/volume] in Serum or Plasma
3485
14131
1.45
75.28
2.9
2.4
mmol/l
0.8
0.8
6.29
3226
12949
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2117
7794
1.58
71.81
4.0
2.7
u/l
238.3
234.8
0.58
1980
7254
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
7629
35419
1.31
70.14
3.1
3.0
—
0.1
—
0
6
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
751
2031
2.12
69.31
2.8
2.1
u/ml
279.2
122.0
0.83
625
1638
(3037467) Urinalysis macro (dipstick) panel - Urine
15746
80265
1.28
68.35
4.5
4.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
2327
8893
1.52
66.67
2.9
2.9
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
360
697
2.94
66.02
5.4
1.1
u/ml
82.8
203.4
1.83
115
166
(3018418) pH of Serum or Plasma
6721
30900
1.31
65.32
4.0
3.1
ph
7.4
7.4
0.64
1266
5236
(3044889) 12 lead EKG panel
15556
79797
1.26
58.95
3.4
3.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
23543
128016
1.54
58.74
10.4
8.3
u/l
24.8
23.8
8.71
22758
123816
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
447
1047
2.43
57.39
2.9
2.0
u/ml
1268.7
344.6
0.69
397
938
(3019225) pH of Specimen
2441
9702
1.46
57.32
3.9
3.3
—
—
—
0
0
(40758558) Short blood count panel - Blood
5772
26408
1.30
56.55
6.2
4.9
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
140
147
5.39
56.12
2.3
1.2
ng/l
76.9
59.0
0.52
59
57
(42870588) Differential panel, method unspecified - Blood
7648
36350
1.27
55.13
5.6
5.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
23260
126396
1.47
53.74
12.5
10.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
17531
91621
1.26
52.98
4.2
4.0
mm/h
11.4
11.3
0.57
16296
85982
(3030467) Casts [#/volume] in Urine by Automated count
5850
27036
1.29
52.33
2.9
2.8
e6/l
0.3
0.4
0.29
4327
19926
(3002582) Erythrocytes [#/volume] in Urine
6326
29542
1.28
52.02
3.0
2.8
e6/l
103.4
53.3
1.25
4762
22038
(3018095) Leukocytes [#/volume] in Urine
7679
36793
1.25
50.56
3.5
3.3
e6/l
95.4
94.8
0.02
5282
24522
(36304419) Bacteria [Presence] in Urine
5778
26798
1.28
49.81
2.9
2.7
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
7286
34897
1.25
47.38
2.4
2.2
u/l
56.4
57.8
0.76
6680
32122
(3042936) Bacteria identified in Isolate by Culture
2926
12435
1.37
46.45
1.9
1.9
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
10963
54935
1.22
46.13
5.7
5.7
%
29.1
29.7
7.56
10135
51233
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
553
5741
0.53
45.02
1.4
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
10644
53288
1.22
44.65
6.0
5.9
%
8.1
8.1
0.15
9900
49988
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
5507
25703
1.26
44.15
2.7
2.7
ng/l
985.5
1042.7
0.44
4552
21476
(3006504) Eosinophils/100 leukocytes in Blood
10592
53061
1.21
43.86
5.7
5.7
%
2.8
2.9
1.73
9788
49399
(3026008) Bacteria identified in Urine by Culture
7362
35629
1.23
42.38
3.1
2.9
—
—
—
0
0
(3026782) Osmolality of Urine
4138
18721
1.29
42.31
2.7
2.5
mosm/kgh2o
512.0
510.0
0.18
3516
15694
(3018010) Neutrophils/100 leukocytes in Blood
10796
54312
1.21
42.20
5.5
5.6
%
56.8
56.3
3.83
10027
50865
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
2004
8126
1.42
41.67
3.4
3.3
ng/l
83.0
79.7
0.93
1704
7006
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
7996
39167
1.22
40.48
3.2
3.0
ng/l
29.1
54.0
1.72
4663
21350
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
21680
117252
1.30
40.12
4.5
4.2
mmol/l
5.8
5.7
8.40
19884
109350
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
3044
13293
1.33
40.01
4.5
4.2
%
32.7
32.9
0.41
2108
9495
(3007461) Platelets [#/volume] in Blood
24424
134828
1.65
39.60
19.8
15.6
e9/l
270.0
266.7
12.36
23935
131545
(3022096) Basophils/100 leukocytes in Blood
10214
51315
1.20
39.55
5.8
5.7
%
0.7
0.7
0.70
9433
47784
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
4167
19015
1.28
39.54
2.6
2.1
mmol/l
2.5
2.4
14.73
3658
16277
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
20409
109657
1.25
38.76
5.5
5.0
mmol/mol
38.9
38.7
4.09
18841
102978
(3010813) Leukocytes [#/volume] in Blood
24439
134980
1.65
38.48
19.8
15.6
e9/l
6.6
6.5
1.20
23891
131348
(3024731) MCV [Entitic volume]
24434
134948
1.65
38.42
19.7
15.5
fl
90.5
90.8
21.45
24167
133216
(3026361) Erythrocytes [#/volume] in Blood
24435
134960
1.64
38.30
19.8
15.6
e12/l
4.5
4.4
0.16
23888
131365
(3035941) MCH [Entitic mass]
24431
134935
1.64
38.24
19.7
15.5
pg
30.0
30.1
37.31
24165
133209
(3000963) Hemoglobin [Mass/volume] in Blood
24439
135000
1.64
38.01
19.9
15.6
g/l
132.7
133.6
25.63
24181
133282
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
3332
14855
1.30
37.59
2.6
2.5
e6/l
4.8
5.2
0.55
1722
7662
(3022145) Colonoscopy Study observation
2808
12288
1.32
36.11
1.3
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
1379
10984
0.69
35.95
1.5
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
11493
58695
1.19
35.76
5.1
4.8
estimate
0.0
0.0
4.20
2179
10283
(3050129) First trimester maternal screen panel - Serum or Plasma
346
3868
0.50
35.64
1.4
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
11589
59250
1.19
35.51
3.8
3.6
estimate
0.0
0.0
0.02
2175
10228
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
21644
117363
1.27
35.31
5.6
5.1
mu/l
2.1
2.0
0.30
20053
110286
(3013115) Eosinophils [#/volume] in Blood
11665
59715
1.19
35.03
5.7
5.7
e9/l
0.2
0.2
1.41
10283
53372
(3019198) Lymphocytes [#/volume] in Blood
11548
59130
1.18
34.28
5.5
5.6
e9/l
1.9
1.9
0.76
10217
52941
(3000850) Epithelial cells [#/volume] in Urine
4414
20644
1.25
33.37
2.5
2.4
e6/l
7.3
7.6
0.59
3801
17866
(3001604) Monocytes [#/volume] in Blood
11216
57368
1.18
33.35
5.5
5.6
e9/l
0.5
0.5
0.05
9707
50467
(3021589) Normoblasts [#/volume] in Blood
9924
50255
1.19
33.07
9.1
7.6
e9/l
0.0
0.0
1.00
8099
41276
(3006315) Basophils [#/volume] in Blood
11253
57614
1.18
32.89
5.5
5.6
e9/l
0.0
0.0
0.19
9718
50627
(3022948) Iron [Moles/volume] in Serum or Plasma
3463
15774
1.27
32.69
2.3
2.3
umol/l
13.3
13.7
2.94
3186
14507
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
161
301
3.03
31.56
1.7
1.4
ug/l
18.9
30.5
0.64
156
293
(3003694) ABO and Rh group [Type] in Blood
5765
27892
1.21
31.25
1.4
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
19274
103534
1.21
31.13
4.7
4.4
pmol/l
14.7
14.5
14.86
17751
96652
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
10475
53476
1.18
30.99
2.3
2.3
nmol/l
8771.2
77.9
0.50
9433
48907
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
5630
27215
1.21
30.69
2.3
2.2
mg/l
3.1
2.8
9.89
4767
23484
(3026493) Urate [Moles/volume] in Serum or Plasma
5760
27933
1.21
30.31
2.2
2.0
umol/l
3288.0
3712.2
0.41
4932
24401
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
2861
12837
1.29
30.25
2.4
2.4
%
22.0
23.0
3.13
2449
10904
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7554
37578
1.19
30.07
3.1
2.7
u/l
30.5
29.9
0.42
7172
35655
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
267
668
2.26
29.91
1.1
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
2114
9116
1.33
29.79
4.2
3.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
2069
8927
1.33
29.01
2.4
2.2
%
1.8
1.8
0.18
1812
7805
(3018677) aPTT in Platelet poor plasma by Coagulation assay
2930
13264
1.28
28.78
2.0
1.9
s
29.4
29.3
0.27
2840
12788
(3035350) Ketones [Presence] in Urine by Test strip
11340
58501
1.17
28.54
3.8
3.6
estimate
0.0
0.0
0.23
2164
10077
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
3576
16625
1.25
27.97
2.5
2.4
e6/l
1.3
1.3
0.02
1968
9343
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
3066
14006
1.27
27.90
1.8
1.7
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
253
2885
0.49
27.70
1.3
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
2634
11819
1.29
27.69
2.3
2.1
umol/l
6.0
5.9
0.17
2227
9861
(3004789) Transferrin [Mass/volume] in Serum or Plasma
3102
14210
1.26
27.55
2.3
2.3
g/l
2.5
2.4
0.42
2841
13047
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
318
3355
0.53
27.27
1.3
1.4
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
260
672
2.19
27.05
3.7
1.5
nmol/l
5.0
3.4
0.88
251
635
(3023520) Reticulocytes [#/volume] in Blood
1520
6323
1.38
26.92
2.5
2.2
e9/l
71.5
71.5
0.02
1120
4685
(3003458) Phosphate [Moles/volume] in Serum or Plasma
2543
11407
1.28
26.75
5.0
4.5
mmol/l
1.0
1.0
0.80
2343
10519
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
298
3184
0.52
26.64
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
298
3182
0.52
26.59
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
297
3171
0.52
26.49
1.3
1.4
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
1117
4414
1.45
26.47
6.0
6.4
mmol/l
25.0
24.9
0.19
1109
4368
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
1856
7989
1.33
26.37
3.5
2.7
mmol/l
1.2
1.2
0.82
1605
6786
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
297
3160
0.52
26.20
1.3
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
15423
81780
1.16
25.72
3.0
2.8
u/l
41.6
36.9
8.63
14422
77191
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
5521
27044
1.19
25.27
1.7
1.7
mg/l
1.0
0.9
1.12
4153
20423
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
689
2503
1.57
24.39
2.1
2.6
g/l
3.5
3.6
1.32
649
2347
(3047352) Trisomy 18 risk [Likelihood] in Fetus
246
2671
0.51
23.21
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
245
2663
0.51
23.19
1.3
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
257
2748
0.52
23.08
1.4
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
5214
33457
0.85
22.71
1.4
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
529
1848
1.63
22.05
2.9
3.5
u/ml
0.4
0.4
0.06
309
1077
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
8974
46076
1.15
21.97
1.9
1.9
pmol/l
101.6
99.9
2.12
4269
22612
(3049717) Cytology report of Urine Cyto stain
574
2048
1.59
21.96
2.2
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
22452
123288
1.24
21.95
4.9
4.5
mmol/l
3.0
2.9
4.38
20698
115811
(3020682) Albumin/Creatinine [Ratio] in Urine
6070
30277
1.17
21.84
3.8
3.8
mg/mmol
8.7
7.2
1.11
3472
17603
(3042111) Morphology [Interpretation] in Bone marrow Narrative
298
885
1.91
21.59
1.7
1.2
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
572
2053
1.58
21.37
1.3
1.3
nmol/l
0.4
0.5
0.18
427
1641
(3014576) Chloride [Moles/volume] in Serum or Plasma
2211
10011
1.27
21.35
6.3
6.0
mmol/l
104.5
104.3
1.29
2180
9780
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
6552
32948
1.16
21.09
2.0
2.0
u/l
148.7
158.8
0.59
6126
30882
(3045142) Bone marrow Pathology biopsy report
208
545
2.16
21.07
1.3
1.1
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
2123
9620
1.27
20.34
2.3
2.2
u/l
38.2
36.4
0.26
1835
8125
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
22140
121577
1.21
19.84
4.4
4.1
mmol/l
5.0
4.9
9.02
20518
114737
(40768797) Stomach Pathology biopsy report
3510
16830
1.20
19.71
1.2
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
21275
116420
1.19
19.62
3.9
3.7
mmol/l
1.3
1.2
50.67
19454
109039
(3012516) Albumin [Mass/volume] in Urine
5762
28831
1.16
19.52
3.1
3.1
mg/l
463.6
412.2
0.28
3236
16436
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
1541
6738
1.31
19.49
1.6
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
233
2428
0.54
19.27
1.7
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
22000
120826
1.20
18.82
4.4
4.1
mmol/l
1.6
1.6
3.27
20295
113763
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
438
1525
1.63
18.58
1.4
1.2
ug/l
4.9
2.8
0.90
331
1354
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
6293
31791
1.15
18.57
1.7
1.6
mmol/l
1.4
1.3
11.55
5248
27316
(3014111) Lactate [Moles/volume] in Serum or Plasma
1534
6752
1.30
18.46
6.3
6.3
mmol/l
1.2
1.3
2.24
1483
6510
(3041096) Erythrocytes [Presence] in Urine by Automated
6383
32321
1.15
18.15
3.4
3.1
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
11020
57924
1.13
17.42
3.0
2.8
ug/l
91.4
80.4
6.13
10244
54460
(3003396) Base excess in Arterial blood by calculation
1913
8724
1.25
17.29
6.6
6.5
mmol/l
1.0
1.3
3.53
1532
6732
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
1914
8732
1.25
17.24
6.6
6.5
kpa
5.1
5.1
0.87
1821
8310
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
53
69
4.33
17.22
1.6
1.1
ug/l
3.3
2.5
0.28
27
45
(3027801) Oxygen [Partial pressure] in Arterial blood
1912
8731
1.25
17.08
6.6
6.5
kpa
13.0
12.2
7.51
1815
8303
(3002173) Hemoglobin [Mass/volume] in Arterial blood
1583
7081
1.28
16.80
7.2
7.3
g/l
119.8
121.0
1.59
1518
6801
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
587
2238
1.49
16.79
1.6
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
1414
6240
1.29
16.68
7.9
7.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
1100
4692
1.34
16.57
1.6
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
18594
101057
1.14
16.38
15.6
12.4
%
13.7
13.6
15.39
18252
98786
(40768443) Skin Pathology biopsy report
1110
4779
1.32
15.69
1.2
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
326
1102
1.68
15.57
1.6
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
2550
12118
1.21
15.51
1.7
1.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
1404
6254
1.28
15.40
7.0
6.6
mmol/l
8.6
8.9
0.68
1326
5947
(3021960) Folate [Moles/volume] in Serum or Plasma
4865
24425
1.15
15.15
1.5
1.5
nmol/l
21.4
21.5
0.15
4088
21138
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
8817
45996
1.12
15.08
3.9
3.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
6144
31351
1.14
15.06
3.0
3.0
mmol/l
6.8
6.8
0.25
5074
26758
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
710
2868
1.41
15.02
2.1
2.4
%
180.4
171.2
1.89
666
2678
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
179
509
1.99
14.85
1.7
1.6
mg/l
2.9
3.0
0.24
166
487
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
2023
9441
1.23
14.75
3.5
3.1
pmol/l
4.5
4.5
0.10
1823
8373
(3020630) Protein [Mass/volume] in Serum or Plasma
1506
6809
1.26
14.63
2.6
1.5
g/l
66.7
67.1
1.25
1331
6115
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
277
914
1.72
14.48
1.9
1.9
u/ml
6.8
316.9
0.89
266
859
(3009343) pH of Capillary blood
1123
4900
1.30
14.44
3.1
3.0
ph
7.4
7.4
0.16
166
601
(3016502) Oxygen saturation in Arterial blood
1664
7633
1.24
14.25
6.9
6.9
%
96.2
95.6
3.30
1596
7327
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
1082
4709
1.31
14.18
3.0
3.0
mmol/l
2.1
1.8
1.14
811
3449
(3004809) Band form neutrophils/100 leukocytes in Blood
312
1074
1.64
13.97
3.1
2.6
%
1.1
1.1
0.26
259
811
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
1132
4972
1.30
13.86
3.1
3.0
kpa
5.2
5.2
0.18
1039
4572
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
2024
9506
1.22
13.85
1.7
1.6
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
1042
4551
1.30
13.32
8.4
8.6
%
94.3
93.5
3.30
1037
4535
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
446
1693
1.49
13.14
1.6
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
200
617
1.83
13.13
1.3
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
191
1881
0.57
13.09
1.3
1.4
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
1035
4528
1.30
13.07
8.4
8.6
%
0.7
0.7
0.06
1029
4504
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
346
1245
1.57
12.99
2.0
2.0
mg/l
24.1
24.4
0.03
99
318
(3016879) Cocaine [Presence] in Urine
475
3819
0.69
12.95
1.3
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
526
4150
0.71
12.86
1.3
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
532
4189
0.71
12.85
1.3
2.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
130
347
2.12
12.80
1.5
1.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
96
1162
0.46
12.76
1.1
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
538
4220
0.71
12.70
1.3
2.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
726
3030
1.36
12.69
1.9
2.1
%
96.1
97.1
0.48
659
2738
(3005719) IgG [Mass/volume] in Serum or Plasma
1767
8260
1.22
12.66
2.7
2.3
g/l
10.2
10.5
2.97
1584
7565
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
862
3694
1.33
12.64
1.9
1.9
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
904
3905
1.32
12.54
8.8
8.7
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
425
1619
1.49
12.34
1.6
1.4
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
15
0
+∞
12.33
1.0
0.0
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
68
923
0.41
12.23
1.3
1.5
mmol/l
8.6
7.8
1.12
38
579
(3027008) Opiates [Presence] in Urine
540
4206
0.72
12.23
1.3
1.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
2021
9607
1.20
12.18
1.7
1.6
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
3873
19404
1.15
12.13
1.7
1.7
nmol/l
1180.0
1197.9
0.55
2859
14990
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
624
2563
1.38
12.06
2.0
1.8
ug/l
1.4
2.1
1.50
527
2214
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
873
3782
1.31
11.88
8.3
8.7
mmol/l
24.4
24.5
0.45
817
3488
(3009542) Hematocrit [Volume Fraction] of Blood
20348
111820
1.13
11.86
14.0
11.5
%
39.2
39.4
4.18
15213
85638
(3025468) Yersinia sp identified in Specimen by Organism specific culture
343
1265
1.53
11.62
1.5
1.3
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
2380
11527
1.18
11.60
21.0
19.3
inr
1.2
1.2
0.26
365
1720
(3028026) IgM [Mass/volume] in Serum or Plasma
1379
6340
1.24
11.58
1.8
1.6
g/l
1.3
1.3
0.62
1251
5800
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
1029
4573
1.28
11.55
8.3
8.4
%
1.3
1.4
3.44
1023
4542
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
308
1110
1.57
11.55
2.3
2.5
u/ml
4534.0
982.8
0.36
11
40
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
565
2304
1.39
11.42
1.4
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
346
1284
1.53
11.41
1.5
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
806
3474
1.32
11.39
3.1
3.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
1799
8531
1.20
11.12
4.0
3.9
%
1.1
0.6
6.21
476
1553
(46235355) HIV 1 and 2 tests - Meaningful Use set
3224
20482
0.87
11.12
1.8
1.8
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
341
1271
1.52
11.04
1.5
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
396
1527
1.47
10.89
1.5
1.7
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
351
1321
1.50
10.86
1.5
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
395
3174
0.70
10.80
1.3
2.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
339
1269
1.51
10.77
1.5
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
580
2401
1.37
10.74
3.6
1.6
mg/l
32.2
34.7
0.24
462
1952
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
715
3057
1.33
10.72
3.3
3.2
mmol/l
25.2
25.0
0.70
653
2797
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
576
2387
1.37
10.60
1.3
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
3841
19397
1.14
10.57
3.2
3.3
ng/l
247.1
337.1
1.03
2581
12715
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
340
1281
1.50
10.49
1.5
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
218
740
1.67
10.44
3.8
2.7
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
704
3016
1.32
10.42
1.3
1.3
u/l
31.0
29.0
0.78
587
2358
(3034860) Kappa light chains.free [Mass/volume] in Serum
580
2415
1.36
10.37
3.6
1.6
mg/l
40.3
38.8
0.18
465
1967
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
97
252
2.17
10.30
2.0
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
1660
7870
1.20
10.29
3.8
3.7
%
0.7
0.5
1.28
352
1164
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
191
628
1.72
10.27
2.8
2.4
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
562
2332
1.37
10.27
3.5
1.6
ratio
1.7
1.5
0.23
34
214
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
772
3358
1.30
10.26
1.8
1.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
4765
24444
1.12
10.09
1.6
1.6
pmol/l
32147848.6
39484035.2
0.37
3935
20720
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
38
59
3.63
10.08
2.4
2.0
pmol/l
59.8
57.1
0.08
30
50
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
59
122
2.73
10.06
1.3
1.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
4942
25410
1.12
10.05
1.4
1.4
g/l
2.2
2.2
2.72
2964
15648
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
790
3457
1.30
10.04
1.7
1.7
g/l
1.5
1.5
0.06
665
2971
(3029937) Albumin [Presence] in Urine by Test strip
5978
31065
1.11
10.00
4.3
4.0
estimate
0.0
0.0
0.15
2188
10287
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
412
1629
1.43
9.98
1.6
1.6
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
432
1723
1.42
9.98
1.3
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
94
245
2.17
9.93
2.0
1.3
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
94
245
2.17
9.93
2.0
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
440
1763
1.41
9.91
3.5
1.6
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
229
802
1.61
9.75
5.8
6.0
mg/l
11.8
11.8
0.03
209
724
(3004588) Protein electrophoresis panel - Serum or Plasma
1255
5826
1.22
9.65
2.3
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
544
2271
1.36
9.60
2.5
2.7
—
—
—
0
0
(3036489) Thrombin time
863
3843
1.27
9.59
1.8
1.9
s
21.2
20.9
0.61
726
3194
(3021440) Promyelocytes/100 leukocytes in Blood
1724
8257
1.19
9.56
4.1
4.0
%
0.2
0.1
3.77
445
1453
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
383
1507
1.44
9.55
1.3
1.2
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
165
532
1.75
9.54
1.4
1.4
g/l
34.1
29.9
2.83
149
465
(3023323) Follitropin [Units/volume] in Serum or Plasma
2213
10833
1.17
9.42
1.3
1.3
iu/l
31.4
31.4
0.03
1951
9600
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
136
415
1.85
9.39
1.6
1.7
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
414
1660
1.41
9.32
1.3
1.2
nmol/l
0.6
1.5
0.72
396
1598
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
332
1279
1.47
9.25
1.4
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
1110
7579
0.82
9.09
1.4
1.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
247
898
1.55
9.04
1.5
1.4
—
—
—
0
0
(3010421) pH of Blood
522
2187
1.35
9.04
3.0
3.2
ph
7.4
7.4
0.25
436
1783
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
412
1664
1.40
8.92
1.3
1.2
nmol/l
0.4
0.2
0.68
21
91
(40760892) CBC W Ordered Manual Differential panel - Blood
5275
27372
1.11
8.92
4.1
4.0
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
2684
13377
1.15
8.92
6.0
5.7
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
1273
5974
1.21
8.81
2.4
2.3
—
—
—
0
0
(3012544) pH of Venous blood
1627
7810
1.19
8.80
3.7
3.5
ph
7.4
7.4
—
5
32
(3036481) Cortisol [Moles/volume] in Serum or Plasma
2262
11153
1.16
8.75
2.1
1.8
nmol/l
365.7
367.3
0.13
2082
10204
(3021447) Carbon dioxide [Partial pressure] in Venous blood
1576
7551
1.19
8.71
3.8
3.5
kpa
5.8
5.9
1.93
1540
7315
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
27
36
4.23
8.67
1.9
3.9
mg/l
1.0
1.7
1.58
16
30
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
2266
14509
0.87
8.63
1.8
1.8
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
374
1496
1.41
8.58
5.0
5.3
iu/ml
583.0
950.2
0.55
44
202
(3012501) Base excess in Blood by calculation
444
1830
1.37
8.55
3.2
3.3
mmol/l
2.5
2.5
0.03
322
1214
(3013290) Carbon dioxide [Partial pressure] in Blood
444
1831
1.37
8.52
3.2
3.3
kpa
5.0
5.0
0.05
436
1784
(3027315) Oxygen [Partial pressure] in Blood
447
1847
1.37
8.48
3.2
3.3
kpa
8.7
8.7
0.20
439
1800
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
363
1449
1.42
8.43
1.4
1.3
pmol/l
297.9
296.4
0.03
287
1127
(3012441) Differential panel - Pleural fluid
124
382
1.83
8.37
1.5
1.5
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
67
163
2.32
8.36
1.7
1.4
u/l
22.8
29.5
0.21
60
140
(3000494) Fungus identified in Specimen by Culture
2613
13059
1.14
8.33
1.4
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
5276
27476
1.10
8.23
3.7
3.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
414
1699
1.38
8.20
2.4
2.3
%
16.3
16.5
0.43
213
832
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
297
1149
1.46
8.16
1.2
1.2
u/l
58.2
56.6
0.22
200
784
(3002032) Base excess in Venous blood by calculation
1561
7523
1.18
8.07
3.8
3.5
mmol/l
2.0
2.1
0.23
1317
6215
(3000570) Elastase.pancreatic [Mass/mass] in Stool
710
3158
1.27
8.04
1.4
1.3
ug/g
301.0
303.1
0.09
389
1735
(3024354) Oxygen [Partial pressure] in Venous blood
1321
6280
1.20
7.99
3.1
3.0
kpa
4.5
4.5
0.25
1286
6075
(3023199) Leukocytes [#/volume] in Pleural fluid
151
501
1.70
7.99
1.4
1.4
e6/l
1914.7
3849.1
1.01
107
364
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
194
691
1.59
7.82
1.8
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
2320
14726
0.88
7.75
1.3
1.3
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
322
1279
1.42
7.73
1.7
1.7
mmol/l
1.6
1.7
1.93
316
1252
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
200
720
1.57
7.71
1.6
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
2003
12834
0.87
7.69
1.8
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
362
1471
1.39
7.64
1.8
1.3
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
382
1574
1.37
7.43
1.5
1.6
mu/l
51.8
53.5
0.08
352
1416
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
51
627
0.46
7.31
1.5
1.2
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
78
215
2.05
7.29
2.0
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
464
1977
1.33
7.28
1.6
1.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
363
1493
1.38
7.16
3.2
3.3
nmol/l
0.8
0.8
1.05
277
1175
(3000475) Leukocytes [#/volume] in Synovial fluid
590
2607
1.28
7.09
1.7
1.7
e6/l
8535.4
10181.2
0.60
439
1898
(3028308) Erythrocytes [#/volume] in Pleural fluid
132
437
1.71
7.09
1.4
1.4
e6/l
35520.8
43311.4
0.17
72
248
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
210
781
1.52
7.06
1.8
1.3
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
1631
7976
1.16
7.06
4.1
4.0
%
0.4
0.1
0.55
388
1269
(3011288) Drugs identified in Urine by Screen method
375
2826
0.74
7.03
1.4
2.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
1761
8671
1.15
6.95
2.7
2.5
e9/l
4.0
4.0
0.03
1370
6933
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
661
4627
0.80
6.94
2.0
1.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
1067
5044
1.20
6.91
2.1
2.1
u/l
40.4
40.0
0.20
948
4600
(3030981) Hyaline casts [#/volume] in Urine by Automated count
1030
4855
1.20
6.88
2.5
2.3
e6/l
0.2
0.3
0.54
988
4628
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
111
353
1.77
6.86
1.8
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
111
353
1.77
6.86
1.8
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
111
353
1.77
6.86
1.8
1.3
—
—
—
0
0
(3036603) Volume of Urine
176
634
1.57
6.83
1.5
1.5
ml
1764.5
1940.4
0.65
36
137
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
533
2337
1.29
6.82
2.4
2.4
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
667
3007
1.26
6.82
2.7
2.5
g/l
0.3
0.3
0.64
224
869
(3045788) Cell count panel - Pleural fluid
120
392
1.73
6.78
1.5
1.5
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
145
499
1.64
6.77
1.5
1.4
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
86
253
1.92
6.76
1.2
1.3
g/l
38.1
37.6
0.14
48
132
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
1121
5340
1.19
6.68
1.5
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
111
356
1.76
6.68
1.8
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
277
1104
1.42
6.60
1.7
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
235
909
1.46
6.57
1.4
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
1885
9367
1.14
6.55
2.4
2.3
au/ml
23.5
24.9
0.16
85
669
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
80
815
0.55
6.47
1.4
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
190
706
1.52
6.46
1.1
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
61
161
2.14
6.41
1.2
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
1082
5166
1.19
6.31
4.6
4.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
79
233
1.91
6.20
4.3
2.7
—
—
—
0
0
(1616796) Gas panel - Central venous blood
413
1774
1.32
6.20
3.1
3.0
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
1079
5160
1.19
6.18
3.0
3.1
g/l
127.9
129.0
0.91
1049
5037
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
1756
8723
1.14
6.14
2.4
2.2
ml/min/173m2
70.5
69.4
0.39
695
3387
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
255
1016
1.42
6.13
1.4
1.3
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
132
456
1.63
6.12
1.3
1.2
mmol/l
6.5
6.8
0.57
119
418
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
2825
17484
0.90
6.11
1.6
1.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
610
2763
1.25
6.04
1.5
1.4
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
338
1416
1.35
6.02
1.4
1.3
nmol/l
41.3
23.5
—
6
12
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
168
618
1.53
6.01
1.6
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
168
618
1.53
6.01
1.6
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
168
618
1.53
6.01
1.6
1.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
450
1967
1.29
5.96
1.5
1.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
3265
16853
1.10
5.94
2.1
2.2
ug/g
110.8
107.5
0.23
2545
13080
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
99
319
1.75
5.92
1.6
1.3
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
812
3803
1.21
5.86
1.9
2.0
iu/l
4.5
16.9
1.18
321
1534
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
693
3195
1.23
5.85
2.2
2.2
mg/l
10.5
10.3
0.30
641
2989
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
846
3991
1.20
5.67
2.9
2.8
%
1.2
1.3
0.55
841
3970
(3042301) Urate [Moles/volume] in Synovial fluid
14
15
5.26
5.67
1.0
1.0
umol/l
316.0
308.2
—
7
5
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
110
371
1.67
5.63
1.5
1.3
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
100
330
1.71
5.54
1.6
1.3
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
104
347
1.69
5.54
1.3
1.2
u/l
305.3
384.9
0.49
96
321
(3042631) Mycobacterium sp identified in Specimen
225
894
1.42
5.54
2.6
2.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
146
531
1.55
5.53
1.3
1.1
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
23
39
3.32
5.52
1.0
1.1
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
611
2800
1.23
5.49
2.2
1.5
g/l
0.5
0.4
0.57
507
2423
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
482
2157
1.26
5.35
3.0
2.8
mg/l
1.5
1.4
0.36
438
1991
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
174
663
1.48
5.34
1.3
1.2
u/l
80.8
84.2
0.22
155
577
(21494814) CD8 cells/100 lymphocytes in Specimen
85
271
1.77
5.31
2.1
1.8
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
83
263
1.78
5.30
1.2
1.2
u/l
12.2
12.2
0.01
73
225
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
126
448
1.59
5.28
1.1
1.1
%
97.9
96.5
0.14
53
194
(3026726) Creatinine [Moles/volume] in Specimen
20
32
3.52
5.21
1.5
4.0
umol/l
776.4
284.2
0.87
20
32
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
20
32
3.52
5.21
1.6
1.9
%
5.8
7.8
—
8
13
(40765096) Chromosome analysis panel by Banding
42
104
2.28
5.19
1.2
1.0
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
1714
8601
1.13
5.17
1.3
1.3
au/ml
54.1
44.6
0.66
52
369
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
88
820
0.60
5.17
10.6
12.3
mmol/l
0.6
0.6
0.07
79
752
(3017354) Segmented neutrophils/100 leukocytes in Blood
184
715
1.45
5.13
3.0
2.5
%
56.2
59.7
1.09
135
460
(3025941) Bacteria identified in Stool by Culture
1486
7395
1.14
5.10
1.2
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
825
3925
1.19
5.09
2.8
2.8
%
0.7
0.7
0.51
799
3738
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
170
652
1.47
5.07
1.3
1.2
u/l
19.1
21.0
0.24
146
555
(1761482) Bacteria [#/volume] in Urine by Culture
535
2440
1.24
5.06
4.0
4.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
138
507
1.54
5.04
1.4
1.2
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
57
162
1.98
5.04
1.1
1.1
pmol/l
25.8
3.2
—
9
18
(3010838) Calcium [Moles/time] in 24 hour Urine
164
626
1.48
5.02
1.8
1.5
mmol/24h
6.6
5.2
0.41
13
66
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
25
48
2.94
5.00
1.3
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
1193
7683
0.87
4.98
1.5
1.5
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
128
464
1.56
4.97
1.1
1.1
%
113.4
116.3
0.41
112
416
(3021901) Oxygen saturation in Capillary blood
321
1377
1.32
4.96
2.6
2.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
212
1642
0.72
4.91
1.7
2.0
umol/l
6.7
6.2
0.23
155
1177
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
136
502
1.53
4.88
1.4
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
166
639
1.47
4.88
2.4
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
67
204
1.85
4.88
1.4
1.6
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
375
1648
1.29
4.86
2.6
2.5
kpa
8.4
8.3
0.25
350
1528
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
5042
26753
1.08
4.81
1.3
1.3
iu/ml
28.3
35.0
1.56
1653
8774
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
772
3673
1.19
4.78
4.9
4.0
mmol/l
24.4
24.4
0.15
717
3259
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
269
1135
1.34
4.68
1.4
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
5797
30943
1.07
4.67
1.3
1.3
u/ml
1.3
1.5
0.69
1556
8984
(3028707) Methadone [Presence] in Urine by Screen method
238
1794
0.74
4.63
1.4
2.6
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
84
279
1.70
4.62
2.1
1.8
%
9.1
8.4
0.17
84
270
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
125
459
1.54
4.62
1.1
1.1
%
91.8
94.5
0.46
49
197
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
105
370
1.60
4.62
1.4
1.2
—
—
—
0
0
(3013862) HLA-DP [Type]
13
16
4.58
4.61
1.1
1.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
711
3372
1.19
4.58
4.5
4.3
%
0.9
0.9
0.33
666
3173
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
280
1193
1.33
4.57
1.2
1.2
u/l
39.0
21.5
1.20
250
1039
(3009466) Valproate [Moles/volume] in Serum or Plasma
220
1674
0.74
4.57
5.5
5.4
umol/l
371.8
383.5
0.58
191
1475
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
105
371
1.60
4.57
1.4
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
164
639
1.45
4.57
1.5
1.9
%
101.2
101.8
0.08
147
577
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
376
1668
1.27
4.55
1.1
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
45
122
2.08
4.54
5.7
1.3
u/l
51.9
37.1
0.48
15
52
(3045414) Leukocytes [Presence] in Urine
1135
5593
1.15
4.54
1.9
1.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
161
626
1.45
4.53
1.6
1.7
%
125.2
129.5
0.33
152
589
(3052851) Hemolysis interference index of Serum or Plasma
636
2990
1.20
4.51
2.8
2.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
718
3416
1.19
4.48
4.4
4.2
%
1.5
1.7
4.18
669
3214
(3035880) pH of Pleural fluid
70
223
1.77
4.46
1.2
1.1
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
161
629
1.44
4.43
2.1
1.9
%
46.9
47.1
0.02
26
105
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
700
3326
1.19
4.43
2.1
1.4
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
669
3166
1.20
4.43
2.2
1.4
g/l
3.0
3.0
0.12
496
2456
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
701
3335
1.19
4.38
2.1
1.4
g/l
7.5
7.4
0.99
514
2486
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
29
66
2.48
4.32
4.0
1.8
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
22
43
2.88
4.30
1.7
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
174
694
1.42
4.30
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
751
3603
1.18
4.27
1.2
1.2
—
—
—
0
0
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
18
31
3.27
4.27
1.3
1.3
u/field
1.1
1.3
0.40
11
25
(4146454)
228
953
1.35
4.26
2.7
2.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
84
286
1.66
4.26
1.2
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
697
3326
1.19
4.22
2.1
1.4
g/l
3.7
3.7
0.18
485
2381
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
264
1130
1.32
4.22
1.0
1.0
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
97
345
1.59
4.15
2.8
2.6
%
43.4
46.0
0.48
31
128
(3020650) Glucose [Presence] in Urine
85
293
1.64
4.12
1.4
1.6
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
48
139
1.95
4.10
2.3
2.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
233
985
1.34
4.07
1.4
1.4
e6/l
84889.9
80330.2
0.04
155
677
(42529406) Shigella sp [Presence] in Stool by Culture
757
3653
1.17
4.03
1.2
1.2
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
1025
5062
1.15
4.01
6.7
6.4
mmol/l
24.7
24.7
0.05
951
4681
(3014765) Yersinia sp identified in Stool by Organism specific culture
756
3650
1.17
4.01
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
370
1669
1.25
3.96
1.4
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
846
4125
1.16
3.96
3.0
2.9
mmol/l
25.5
25.5
0.01
825
3993
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
20
39
2.89
3.94
2.0
2.0
%
62.5
63.1
0.02
13
20
(46236302) HLA-C [Type] by High resolution typing
12
16
4.23
3.92
1.1
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
12
16
4.23
3.92
1.1
1.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
12
16
4.23
3.92
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
12
16
4.23
3.92
1.1
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
12
16
4.23
3.92
1.1
1.0
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
4814
25677
1.07
3.90
1.3
1.3
u/ml
8.3
11.6
3.42
1895
10659
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
308
1362
1.28
3.89
1.4
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
1557
7911
1.12
3.87
1.4
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
8751
47546
1.06
3.85
2.8
2.6
—
—
—
0
0
(3003338) MCHC [Mass/volume]
18563
106179
0.94
3.85
16.6
13.6
g/l
330.5
331.1
19.55
18441
105423
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
168
683
1.39
3.78
1.6
1.5
u/l
5.0
6.4
0.55
76
331
(3044927) Protein electrophoresis panel - Urine
193
804
1.35
3.75
1.2
1.2
—
—
—
0
0
(3039000) Anion gap in Blood
388
1778
1.23
3.64
5.8
5.7
mmol/l
11.1
11.1
0.00
346
1602
(3011412) CD3 cells [#/volume] in Blood
191
799
1.35
3.62
2.4
2.2
e9/l
1.2
1.3
0.20
116
442
(3018572) Chloride [Moles/volume] in Blood
388
1779
1.23
3.62
5.8
5.7
mmol/l
105.2
104.9
0.56
346
1603
(3012565) Volume of 24 hour Urine
122
472
1.46
3.62
2.1
1.8
ml
1821.2
2032.5
1.86
113
431
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
89
322
1.56
3.60
1.4
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
89
322
1.56
3.60
1.4
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
61
200
1.72
3.60
2.1
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
46
138
1.88
3.60
2.4
2.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
67
226
1.67
3.58
1.3
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
644
3101
1.17
3.57
2.1
1.4
g/l
10.0
10.2
0.44
523
2591
(3008037) Lactate [Moles/volume] in Venous blood
412
1907
1.22
3.53
2.7
2.8
mmol/l
1.5
1.5
0.56
402
1870
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
551
2622
1.19
3.52
2.0
1.4
g/l
38.1
38.3
0.42
459
2235
(3006184) Hemoglobin [Mass/volume] in Capillary blood
438
2041
1.21
3.51
2.1
2.0
g/l
129.7
129.6
0.02
308
1480
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
84
302
1.57
3.50
2.9
2.9
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
28
70
2.25
3.49
1.5
1.2
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
92
339
1.53
3.46
1.5
1.6
ug/l
0.4
0.4
0.55
61
224
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
139
557
1.41
3.44
2.7
2.4
e6/l
716.7
1044.6
1.05
63
257
(3013139) Helicobacter pylori Ag [Presence] in Stool
1893
9783
1.10
3.41
1.2
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
315
2196
0.81
3.40
1.0
1.1
u/ml
4.1
3.9
0.04
104
769
(3023487) Leukocytes [#/volume] in Peritoneal fluid
54
174
1.75
3.40
2.4
2.3
e6/l
677.2
721.5
0.05
35
122
(3020876) Protein [Mass/time] in 24 hour Urine
148
601
1.39
3.40
2.0
1.7
g/24h
0.7
1.2
0.78
12
39
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
305
1373
1.25
3.39
1.6
1.6
%
50.4
51.7
0.23
198
829
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
219
1591
0.77
3.37
1.2
1.2
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
20
43
2.62
3.37
1.3
1.0
—
—
—
0
0
(4094501)
622
3003
1.17
3.36
1.1
1.1
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
135
541
1.41
3.35
1.1
1.1
u/l
78.4
77.5
0.05
114
416
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
24
57
2.37
3.34
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
1084
5444
1.13
3.34
3.3
3.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
2297
13948
0.92
3.33
1.3
1.4
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
38
110
1.95
3.32
2.0
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
108
418
1.46
3.24
1.4
1.3
—
—
—
0
0
(1002224) Polysomnography panel
1118
5639
1.12
3.22
1.1
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
426
1999
1.20
3.21
2.7
2.7
mmol/l
25.1
25.0
0.12
379
1745
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
7
5
7.89
3.16
1.1
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
7
5
7.89
3.16
1.0
1.0
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
134
543
1.39
3.15
1.1
1.1
u/l
21.5
18.6
0.26
108
402
(3017143) Hepatitis C virus Ab [Presence] in Serum
2405
12610
1.08
3.12
1.6
1.5
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
43
133
1.82
3.12
1.3
1.3
%
63.8
54.7
0.87
37
108
(40761539) Cells [Type] in Urine sediment by Light microscopy
57
192
1.67
3.11
1.2
1.1
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
775
3829
1.14
3.11
3.6
3.5
%
48.3
47.8
0.24
767
3788
(3020891) Body temperature
677
3313
1.16
3.10
4.6
4.4
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
386
1805
1.21
3.04
2.8
2.9
mmol/l
7.4
7.4
0.02
377
1771
(3003327) Ova and parasites identified in Stool by Light microscopy
929
4652
1.13
3.04
1.8
1.7
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
364
2468
0.83
3.03
1.1
1.1
u/ml
2.0
1.7
0.11
71
551
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
527
2537
1.17
3.00
2.1
1.4
g/l
0.0
0.0
0.20
469
2325
(3024980) IgG subclass 4 [Mass/volume] in Serum
407
1916
1.20
2.99
1.5
1.5
g/l
0.6
0.6
0.06
289
1482
(3023183) Ammonium ion [Moles/volume] in Plasma
317
1457
1.23
2.97
2.9
2.9
umol/l
32.6
32.7
0.03
266
1262
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
485
2321
1.18
2.97
2.1
1.4
g/l
0.0
0.0
0.50
430
2116
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
47
152
1.74
2.97
1.1
1.2
nmol/l
0.4
0.4
0.13
33
99
(3024928) Oxygen saturation in Venous blood
358
1667
1.21
2.96
3.4
3.6
—
—
—
0
0
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
73
266
1.55
2.94
1.1
1.1
%
86.8
94.9
0.39
11
58
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
148
618
1.35
2.92
1.9
1.8
%
14.4
13.4
0.45
60
338
(3026692) Albumin [Mass/volume] in Peritoneal fluid
42
132
1.79
2.92
1.4
1.4
g/l
14.8
10.3
1.62
30
88
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
95
367
1.46
2.92
1.3
1.4
u/l
12.2
12.4
0.07
89
356
(3033705) Calcium.ionized [Moles/volume] in Venous blood
232
1032
1.27
2.91
1.9
2.2
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
563
2733
1.16
2.90
2.1
2.1
ug/l
546.8
487.4
0.13
512
2495
(4010399)
1652
8554
1.09
2.90
1.4
1.4
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
18
40
2.54
2.88
3.9
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
1722
8938
1.09
2.86
3.4
3.5
—
—
—
0
0
(4198724)
49
447
0.62
2.83
1.2
2.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
121
492
1.39
2.83
1.1
1.0
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
555
2702
1.16
2.77
4.9
4.8
mmol/l
1.3
1.2
0.13
489
2389
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
112
452
1.40
2.74
1.7
1.7
%
142.2
148.4
0.33
104
417
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
47
157
1.69
2.69
2.3
2.0
e6/l
28656.8
16737.9
0.21
21
81
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
568
2779
1.15
2.67
1.6
1.5
iu/ml
21.4
17.1
0.25
20
91
(3024263) Appearance of Synovial fluid
128
532
1.36
2.64
2.0
1.8
—
—
—
0
0
(3048879) Bone marrow aspiration report
50
171
1.65
2.63
2.0
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
475
2297
1.17
2.61
2.2
1.4
g/l
0.0
0.0
0.00
428
2109
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
90
354
1.43
2.56
2.3
2.4
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
8
10
4.51
2.55
1.0
1.2
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
12
165
0.41
2.54
1.1
1.2
—
—
—
0
0
(3009015) Lactate [Moles/volume] in Synovial fluid
32
97
1.86
2.52
1.3
1.3
mmol/l
5.5
5.1
0.22
18
48
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
71
268
1.49
2.49
1.1
1.1
%
67.9
78.2
—
8
56
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
69
260
1.50
2.45
1.1
1.1
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
390
1869
1.18
2.42
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
390
1869
1.18
2.42
1.3
1.3
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
212
957
1.25
2.42
3.4
8.1
mmol/l
7.4
7.4
0.00
174
770
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
684
3416
1.13
2.41
1.3
1.3
u/ml
46.6
45.0
0.09
91
358
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
136
580
1.32
2.41
2.0
1.9
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
59
216
1.54
2.39
1.8
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
38
124
1.73
2.39
1.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
285
1926
0.83
2.38
1.2
1.3
mmol/l
7.3
7.2
0.36
207
1409
(3027923) C peptide [Moles/volume] in Serum or Plasma
124
523
1.34
2.37
1.5
1.8
nmol/l
1.2
1.3
0.52
94
431
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
211
955
1.25
2.36
1.5
1.5
g/l
1.0
0.9
0.93
211
948
(3003888) Timothy IgE Ab [Units/volume] in Serum
406
2661
0.86
2.35
1.1
1.1
u/ml
2.7
3.7
1.02
167
1264
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
800
4041
1.12
2.35
1.3
1.3
u/ml
8.8
7.1
0.28
141
672
(4212803)
21
56
2.11
2.34
1.0
1.1
—
—
—
0
0
(44806118)
193
866
1.26
2.33
1.5
1.5
—
—
—
0
0
(44790049)
193
866
1.26
2.33
1.5
1.5
—
—
—
0
0
(3041918) Cholesterol [Moles/volume] in Pleural fluid
33
104
1.79
2.33
1.2
1.1
mmol/l
2.2
1.9
0.43
16
47
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
22
60
2.07
2.32
1.2
1.3
ug/l
1336.0
44.1
0.64
13
32
(3008401) Mugwort IgE Ab [Units/volume] in Serum
386
2536
0.86
2.32
1.1
1.1
u/ml
0.9
0.8
0.07
130
969
(44790048)
193
867
1.26
2.31
1.5
1.5
—
—
—
0
0
(44790047)
193
867
1.26
2.31
1.5
1.5
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
94
381
1.39
2.31
2.7
3.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
467
3024
0.87
2.31
1.2
1.3
—
—
—
0
0
(3022475) Manganese [Moles/volume] in Blood
27
80
1.90
2.29
1.3
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
1401
7286
1.09
2.29
1.1
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
785
4917
0.90
2.28
1.4
1.3
miu/ml
213.5
223.5
0.35
367
2483
(3006922) Hepatitis E virus Ab [Presence] in Serum
174
774
1.27
2.27
1.1
1.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
17
42
2.28
2.25
1.1
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
811
4114
1.11
2.22
1.4
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
454
2935
0.87
2.21
1.1
1.1
u/ml
1.6
1.2
0.25
149
1048
(3023430) Cat dander IgE Ab [Units/volume] in Serum
310
2059
0.85
2.16
1.0
1.1
u/ml
3.9
3.7
0.09
105
787
(3032868) Hemoglobin electrophoresis panel in Blood
23
66
1.96
2.15
1.5
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
358
1724
1.17
2.14
1.1
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
65
524
0.70
2.14
1.2
1.2
—
—
—
0
0
(4024509)
237
1100
1.22
2.13
1.7
1.6
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
87
354
1.39
2.12
32.8
36.3
ug/l
7.2
7.2
0.02
77
329
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
92
378
1.37
2.11
2.3
2.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
784
3984
1.11
2.10
1.3
1.3
u/ml
3.6
6.5
1.01
97
429
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
865
4419
1.11
2.10
1.3
1.3
u/ml
29.0
39.7
0.53
49
308
(3022621) pH of Urine by Test strip
1515
7937
1.08
2.09
3.1
2.9
—
—
—
0
0
(3002331) Protein [Mass/volume] in Peritoneal fluid
33
108
1.72
2.09
1.6
1.5
g/l
23.8
21.6
0.30
25
70
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
386
1875
1.16
2.08
1.4
1.4
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
32
295
0.61
2.03
2.0
1.9
umol/l
17.3
17.2
0.02
32
295
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
230
1071
1.21
2.02
1.2
1.1
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
20
56
2.01
2.00
1.1
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
735
3734
1.11
2.00
1.2
1.2
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
3679
19852
1.05
2.00
1.4
1.4
titre
502.6
620.5
3.54
781
4315
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
196
900
1.23
1.98
1.3
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
195
895
1.23
1.98
1.3
1.2
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
39
136
1.62
1.98
1.5
1.4
pmol/l
59.5
41.3
0.29
32
111
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
29
93
1.76
1.98
1.7
2.2
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
33
110
1.69
1.98
1.1
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
36
123
1.65
1.98
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
398
1947
1.15
1.97
1.2
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
180
820
1.24
1.96
1.3
1.3
g/l
1.5
1.5
—
9
50
(3043681) Transitional cells [#/area] in Urine by Computer assisted method
17
45
2.13
1.95
1.1
1.0
u/field
1.9
1.3
—
10
33
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
34
115
1.67
1.94
1.2
1.1
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
218
1015
1.21
1.94
1.2
1.1
nmol/l
373.4
390.2
0.60
194
884
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
39
137
1.60
1.93
1.1
1.0
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
19
53
2.02
1.93
1.1
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
97
409
1.34
1.92
1.1
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
67
266
1.42
1.90
3.3
2.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
588
2960
1.12
1.90
1.1
1.1
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
864
4440
1.10
1.89
1.5
1.5
u/ml
11.9
11.8
0.00
23
100
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
15282
87263
0.97
1.89
3.1
3.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
269
1782
0.85
1.86
1.0
1.0
u/ml
0.1
0.4
1.04
53
318
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
181
831
1.23
1.86
1.5
1.4
nmol/l
1.7
1.5
1.19
163
750
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
23
70
1.85
1.85
1.1
1.0
u/ml
0.1
0.1
—
8
26
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
20
58
1.94
1.85
1.3
1.2
%
13.8
13.1
0.04
11
30
(4211845)
135
600
1.27
1.84
4.1
2.8
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
47
389
0.68
1.84
2.0
2.4
nmol/l
154.7
164.7
0.28
38
348
(3000919) Neutrophils/100 leukocytes in Pleural fluid
31
104
1.68
1.84
1.3
1.3
%
23.9
25.8
0.12
31
96
(3043409) Potassium [Moles/volume] in Arterial blood
493
2462
1.13
1.83
4.4
4.2
mmol/l
3.8
3.8
0.24
470
2325
(3025315) Body weight
24
75
1.80
1.80
4.4
3.9
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
23
71
1.83
1.79
1.6
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
1412
7431
1.07
1.78
2.1
2.2
ug/l
5.5
6.0
0.51
1161
6420
(3018405) Lactate [Moles/volume] in Arterial blood
554
2793
1.12
1.77
4.1
4.0
mmol/l
1.3
1.3
0.12
542
2745
(3024869) Neuronal Ab [Presence] in Serum
37
132
1.58
1.75
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
154
701
1.24
1.74
1.1
1.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
163
747
1.23
1.73
1.6
1.6
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
60
469
0.72
1.72
1.2
1.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
35
124
1.59
1.71
1.3
1.2
mmol/l
3.1
3.2
0.05
28
114
(37021550) Renin [Units/volume] in Plasma --upright
60
241
1.40
1.64
1.4
1.3
mu/l
60.1
57.7
0.05
41
183
(3047007) Chlamydophila sp Ab [Presence] in Serum
424
2115
1.13
1.64
1.3
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
71
294
1.36
1.63
1.4
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
323
1583
1.15
1.63
1.1
1.1
iu/ml
34.7
8007.5
0.65
79
341
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
154
707
1.23
1.63
1.1
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
182
850
1.21
1.62
2.3
2.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
1434
7579
1.07
1.62
2.6
2.6
ng/l
160.4
161.2
0.02
1298
6869
(3035933) Granulocytes/100 leukocytes in Blood
73
304
1.35
1.62
1.3
2.1
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
123
551
1.26
1.62
4.2
2.8
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
5
7
4.02
1.61
1.0
1.1
nmol/24h
21.8
21.8
—
5
7
(3016244) Insulin [Units/volume] in Serum or Plasma
182
851
1.21
1.61
3.3
3.7
mu/l
28.4
30.3
0.23
172
818
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
56
437
0.72
1.61
1.8
1.7
ug/l
8.8
8.6
0.21
56
437
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
1031
5389
1.08
1.59
1.7
1.6
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
77
325
1.34
1.58
24.8
25.6
ug/l
117.0
118.4
0.07
56
267
(3004716) Salmonella sp identified in Stool by Organism specific culture
1366
7217
1.07
1.57
1.4
1.5
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
112
498
1.27
1.57
1.6
1.7
umol/l
2.0
2.0
0.15
105
465
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
373
1852
1.14
1.57
1.3
1.2
u/ml
293.6
283.6
0.29
237
1277
(3015171) Extractable nuclear Ab [Units/volume] in Serum
1204
6334
1.07
1.57
1.3
1.3
u/ml
1.4
0.8
0.60
119
552
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
35
295
0.67
1.55
1.2
1.2
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
11
27
2.30
1.52
1.2
1.1
—
—
—
0
0
(3037297) Penicillin G IgE Ab [Units/volume] in Serum
20
63
1.79
1.49
1.1
1.0
u/ml
0.0
0.1
—
6
20
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
14
39
2.02
1.46
10.1
1.6
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
155
722
1.21
1.46
1.1
1.1
nmol/l
2.8
4.2
0.22
31
132
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
260
1687
0.87
1.45
1.4
1.6
—
—
—
0
0
(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma
24
81
1.67
1.44
3.0
3.1
mmol/l
0.5
1.2
1.83
16
57
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
60
1.78
1.42
1.2
1.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
131
602
1.23
1.41
1.8
1.6
nmol/l
2.6
11.8
0.51
116
485
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
416
2096
1.12
1.41
1.1
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
658
3396
1.09
1.40
1.3
1.2
titre
136.7
142.2
0.06
55
295
(3018001) Oat IgE Ab [Units/volume] in Serum
11
121
0.51
1.39
1.1
1.0
u/ml
0.2
0.2
—
5
44
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
15
44
1.92
1.38
3.5
1.0
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
65
274
1.34
1.38
1.2
1.2
pmol/l
389.9
332.7
0.48
51
203
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
20
65
1.73
1.37
1.3
1.2
u/l
35.7
611.9
0.52
13
39
(3030313) Adrenal Ab [Titer] in Serum
15
149
0.57
1.36
1.1
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
399
2012
1.12
1.35
1.2
1.3
titre
132.0
86.5
—
5
37
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
378
2380
0.89
1.34
1.7
1.7
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
18
57
1.78
1.34
2.0
2.4
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
10
25
2.25
1.34
1.3
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
382
1923
1.12
1.33
1.1
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
37
142
1.47
1.33
5.6
5.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
347
1738
1.13
1.32
1.4
1.4
u/ml
125.6
114.6
0.40
73
423
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
13
37
1.98
1.30
1.2
1.1
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
189
908
1.17
1.30
1.1
1.1
mg/l
298.3
628.5
0.50
169
812
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
689
3579
1.09
1.29
1.7
1.6
titre
311.7
299.2
0.04
33
190
(3034770) Mitochondria Ab [Titer] in Serum
659
3417
1.09
1.29
1.2
1.2
titre
640.0
1053.5
1.52
24
160
(3000034) Microalbumin [Mass/volume] in Urine
199
962
1.17
1.27
2.5
2.8
mg/l
35.5
40.6
0.12
129
642
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
137
641
1.21
1.27
1.3
1.3
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
131
611
1.21
1.26
2.5
2.2
e9/l
0.2
0.2
0.84
118
515
(3051593) INR in Capillary blood by Coagulation assay
82
363
1.27
1.25
8.3
8.9
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
176
1159
0.85
1.24
1.3
1.3
u/ml
0.5
1.1
1.23
84
487
(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum
9
97
0.52
1.24
1.0
1.0
u/ml
0.3
0.4
—
9
83
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
30
112
1.51
1.24
1.1
1.1
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
15
46
1.84
1.24
1.0
1.0
—
—
—
0
0
(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method
10
26
2.17
1.24
10.3
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
128
597
1.21
1.23
1.0
1.0
%
95.0
95.2
0.02
98
468
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
176
845
1.17
1.23
1.1
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
43
173
1.40
1.23
1.3
1.3
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
13
130
0.56
1.23
2.6
2.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
466
2385
1.10
1.23
3.8
3.3
mg/l
23.5
22.9
0.11
294
1469
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
8
20
2.25
1.22
3.3
3.1
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
18
59
1.72
1.22
1.1
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
134
629
1.20
1.21
2.5
2.2
e6/l
446.8
525.5
0.63
118
518
(3001186) Copper [Moles/volume] in Serum or Plasma
73
320
1.29
1.21
1.3
1.4
umol/l
17.3
17.9
0.64
64
279
(3003157) Bacteria [#/volume] in Mother's milk
0
21
0.00
1.21
0.0
6.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
61
261
1.32
1.21
1.1
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
54
227
1.34
1.20
1.3
1.1
—
—
—
0
0
(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum
0
22
0.00
1.19
0.0
1.0
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
1037
5494
1.07
1.17
1.1
1.1
u/ml
0.9
3.1
0.95
18
89
(3014051) Protein [Presence] in Urine by Test strip
530
2737
1.09
1.17
2.1
2.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
99
453
1.23
1.16
1.1
1.2
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
14
43
1.83
1.16
1.2
1.4
nmol/l
560.5
423.0
0.50
14
43
(3009214) Lutropin [Units/volume] in Serum or Plasma
502
2588
1.09
1.15
1.2
1.2
u/l
18.5
14.4
4.89
425
2099
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
43
176
1.38
1.14
1.9
2.6
mmol/l
6.8
7.2
0.39
31
103
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
1691
9096
1.05
1.13
1.6
1.7
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
23
83
1.56
1.12
1.6
1.6
—
—
—
0
0
(3042934) Triiodothyronine (T3) Ab [Presence] in Serum
7
17
2.32
1.11
1.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
12
118
0.57
1.09
1.5
1.2
—
—
—
0
0
(3027974) Hepatitis B virus e Ag [Presence] in Serum
17
57
1.68
1.08
1.8
1.4
—
—
—
0
0
(4306422)
379
1937
1.10
1.06
1.2
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
110
515
1.20
1.06
2.0
2.1
ug/l
2.5
3.0
0.62
94
435
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
157
759
1.17
1.05
1.1
1.1
u/l
1.0
1.1
0.61
75
313
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
22
80
1.55
1.05
1.1
1.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
389
1995
1.10
1.03
2.3
2.1
nmol/l
0.9
0.8
0.36
323
1678
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
14
45
1.75
1.03
2.1
5.1
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
142
683
1.17
1.02
1.5
1.4
ug/l
8.6
7.4
0.38
125
604
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
26
99
1.48
1.02
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
198
979
1.14
1.00
1.1
1.1
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
122
581
1.18
0.99
1.2
1.2
%
52.8
58.7
0.26
13
65
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
25
95
1.48
0.99
1.4
1.4
%
25.9
26.4
0.02
19
77
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
21
176
0.67
0.99
1.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
60
265
1.28
0.99
1.2
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
43
319
0.76
0.99
2.5
3.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
42
177
1.34
0.96
1.7
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
80
549
0.82
0.96
1.2
2.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
28
110
1.43
0.95
1.1
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
788
4716
0.94
0.94
1.6
1.6
mu/l
320.3
331.1
0.31
709
4196
(4062490)
253
1276
1.12
0.94
1.4
1.4
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
5
60
0.47
0.93
1.0
1.0
—
—
—
0
0
(3042010) Triglyceride [Moles/volume] in Pleural fluid
21
78
1.52
0.93
1.2
1.1
mmol/l
0.3
1.7
1.08
11
38
(36660697) Celiac disease serology panel - Serum
2024
10991
1.04
0.93
1.2
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
71
323
1.24
0.93
1.9
1.6
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
131
633
1.17
0.92
1.7
1.7
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
203
1013
1.13
0.91
1.1
1.1
iu/ml
7.0
8.2
0.27
62
247
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
2306
13429
0.96
0.91
1.5
1.6
%
1.3
1.3
0.02
2048
11981
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
49
214
1.29
0.90
1.1
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
67
464
0.81
0.90
1.0
1.1
u/ml
10.9
8.0
0.22
14
73
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
178
882
1.14
0.89
1.3
1.3
mmol/l
2.1
2.0
0.33
167
818
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
12
111
0.61
0.89
9.3
7.2
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
152
745
1.15
0.89
1.4
1.4
u/l
5.3
5.3
0.03
132
608
(3028192) IgG subclass 2 [Mass/volume] in Serum
251
1271
1.11
0.89
1.4
1.4
g/l
2.9
3.0
0.37
165
928
(3024139) IgG subclass 3 [Mass/volume] in Serum
251
1272
1.11
0.88
1.4
1.4
g/l
0.4
0.4
0.07
168
933
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
61
275
1.25
0.88
1.3
1.4
%
42.8
41.9
0.06
40
189
(3017509) Phencyclidine [Presence] in Urine
14
124
0.64
0.87
1.4
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
213
1070
1.12
0.87
1.3
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
200
1001
1.13
0.87
3.1
2.9
—
—
—
0
0
(3004451) EKG impression Narrative
80
373
1.21
0.85
1.2
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
87
409
1.20
0.85
1.2
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
28
113
1.40
0.85
13.8
9.7
mmol/l
4.9
4.4
0.64
28
113
(3020123) Porphyrins [Interpretation] in Serum or Plasma
21
80
1.48
0.85
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
209
1051
1.12
0.85
1.3
1.2
titre
—
—
—
0
0
(3019977) pH of Arterial blood
88
415
1.20
0.84
3.1
2.6
ph
7.4
7.4
0.23
32
119
(3049242) von Willebrand panel - Platelet poor plasma
10
31
1.82
0.83
2.3
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
97
462
1.18
0.83
1.1
1.1
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
13
44
1.66
0.83
1.0
1.0
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
15
53
1.59
0.82
1.3
1.2
ug/l
133.1
126.9
—
10
36
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
202
1016
1.12
0.82
1.1
1.1
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
33
246
0.76
0.82
1.2
1.2
u/ml
0.1
10.9
—
8
50
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
26
201
0.73
0.82
1.2
1.1
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
159
788
1.14
0.82
1.4
1.4
umol/l
10.5
11.0
0.53
152
752
(3027135) IgG subclass 1 [Mass/volume] in Serum
250
1273
1.11
0.82
1.4
1.4
g/l
6.5
6.7
0.29
164
930
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
39
284
0.77
0.82
1.3
1.3
mg/l
0.8
47.0
1.37
29
207
(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma
18
67
1.51
0.81
1.0
1.0
u/l
33.9
53.3
1.25
13
55
(21491868) Cryoglobulin [Mass/volume] in Serum
62
427
0.82
0.81
1.1
1.2
g/l
0.3
0.1
—
5
19
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
5
58
0.49
0.81
1.0
1.1
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
6
18
1.88
0.79
1.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
6
18
1.88
0.79
1.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
6
18
1.88
0.79
2.0
2.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
6
18
1.88
0.79
1.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
6
18
1.88
0.79
2.0
1.9
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
6
18
1.88
0.79
2.0
1.9
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
9
28
1.81
0.79
1.0
1.3
—
—
—
0
0
(3003721) Smooth muscle Ab [Units/volume] in Serum
27
110
1.38
0.79
1.1
1.1
u/ml
3.2
2.3
—
5
9
(3038177) Helicobacter pylori Ab [Presence] in Serum
462
2423
1.08
0.79
1.2
1.2
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
283
1454
1.10
0.78
1.1
1.1
g/l
1.5
1.5
0.03
255
1305
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
158
787
1.13
0.77
3.9
3.8
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
46
325
0.80
0.77
1.0
1.1
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
128
629
1.15
0.76
1.3
1.3
u/l
267.7
287.2
0.09
120
589
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
27
111
1.37
0.76
1.1
1.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
5
13
2.17
0.76
4.0
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
96
462
1.17
0.75
3.4
3.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
110
536
1.16
0.74
2.0
2.1
ug/l
3.3
4.3
0.69
101
475
(3044290) Cell count panel - Cerebral spinal fluid
469
2472
1.07
0.72
1.2
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
246
1264
1.10
0.71
1.2
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
36
157
1.29
0.70
1.1
1.1
—
1.2
—
0
11
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
14
117
0.67
0.70
1.4
1.5
mg/l
1.0
2.3
—
9
81
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
580
3083
1.06
0.69
1.2
1.2
u/ml
19.9
12.6
—
8
52
(40765089) Chromosome analysis panel - Blood by G-banded
27
201
0.76
0.69
1.0
1.0
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
66
443
0.84
0.69
3.1
2.9
umol/l
28.6
27.7
0.17
57
333
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
52
239
1.23
0.68
1.1
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
19
75
1.43
0.67
1.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
389
2043
1.07
0.67
1.4
1.3
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
11
38
1.63
0.67
1.4
1.1
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
354
1855
1.08
0.66
1.1
1.1
%
125.1
123.0
0.59
320
1669
(3038071) Oxygen [Partial pressure] in Mixed venous blood
18
141
0.72
0.65
22.1
7.0
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
5
16
1.76
0.63
1.0
1.1
titre
1278.0
2342.5
—
5
16
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
87
423
1.16
0.63
1.1
1.1
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
210
1079
1.10
0.63
1.1
1.2
mg/l
41.0
37.6
0.31
172
907
(3006598) pH of Arterial cord blood
0
13
0.00
0.62
0.0
1.2
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
28
1.61
0.62
1.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
13
107
0.68
0.62
3.8
7.6
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
98
482
1.15
0.62
2.3
1.9
umol/l
20.0
14.3
—
8
50
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
600
3209
1.05
0.61
1.3
1.3
u/ml
6.8
6.6
0.02
45
245
(3017704) Immunofixation for Urine
84
409
1.16
0.61
1.8
1.3
—
—
—
0
0
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
14
113
0.70
0.60
1.4
1.5
mg/l
2.0
2.4
—
8
82
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
14
113
0.70
0.60
1.4
1.5
mg/l
1.4
2.7
—
7
80
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
14
113
0.70
0.60
1.4
1.5
mg/l
2.0
1.9
—
9
70
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
14
113
0.70
0.60
1.4
1.5
mg/l
0.8
1.0
—
9
76
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
31
136
1.28
0.60
1.6
2.4
—
—
—
0
0
(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma
31
136
1.28
0.60
1.2
1.2
ng/l
46.9
55.7
0.21
22
82
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
4611
26411
0.98
0.60
1.5
1.6
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
8
29
1.55
0.60
1.0
1.0
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
8
29
1.55
0.60
1.3
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
8
29
1.55
0.60
1.0
1.1
nmol/l
350.6
266.3
—
8
29
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
167
1038
0.91
0.60
1.4
1.3
mmol/l
11.9
11.2
0.32
41
216
(3020961) Endomysium IgA Ab [Titer] in Serum
1287
7006
1.04
0.60
1.1
1.1
titre
166.8
180.0
0.07
23
158
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
57
381
0.84
0.60
1.1
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
119
595
1.13
0.59
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
1709
9911
0.97
0.59
1.8
1.7
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
6
19
1.78
0.59
1.5
1.1
%
1.7
1.6
—
6
19
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
39
177
1.24
0.59
1.4
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
1710
9358
1.03
0.58
1.3
1.3
u/ml
133.2
184.4
2.98
1581
8707
(3015076) Soybean IgE Ab [Units/volume] in Serum
136
852
0.90
0.57
1.0
1.0
u/ml
0.2
0.3
0.37
19
89
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
202
1042
1.09
0.57
1.1
1.1
mg/l
250.7
225.7
0.89
176
920
(44813793)
211
1092
1.09
0.56
1.1
1.1
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
88
565
0.88
0.56
1.2
1.2
g/l
0.3
0.3
0.42
71
446
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
425
2258
1.06
0.56
1.1
1.1
au/ml
18.0
11.0
0.57
25
140
(3034092) Cytoplasmic Ig cells/100 cells in Blood
35
158
1.25
0.56
5.3
8.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
29
128
1.28
0.55
1.1
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
16
64
1.41
0.55
2.5
1.5
umol/24h
417.2
272.1
1.36
16
64
(3017569) Oxygen content in Arterial blood
69
335
1.16
0.54
1.8
2.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
25
180
0.78
0.54
1.1
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
9
78
0.65
0.53
1.0
1.1
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
376
1994
1.06
0.53
1.3
1.3
u/ml
44.8
62.4
0.79
26
155
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
178
917
1.09
0.53
2.2
2.0
u/field
2.7
2.4
0.22
84
369
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
24
104
1.30
0.52
1.9
2.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
290
1527
1.07
0.52
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
226
1179
1.08
0.51
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
396
2108
1.06
0.51
1.1
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
46
217
1.19
0.50
1.3
1.3
—
—
—
0
0
(3016750) Collection duration of Urine
78
500
0.88
0.50
2.4
2.1
min
489.1
498.0
0.34
61
401
(3025018) Bordetella pertussis Ab [Titer] in Serum
179
926
1.09
0.50
1.3
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
396
2109
1.06
0.50
1.1
1.1
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
488
2889
0.95
0.50
1.6
1.7
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
56
270
1.17
0.49
1.0
1.0
ug/l
82.0
80.4
0.11
48
225
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
7
26
1.52
0.48
1.1
1.0
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
128
654
1.10
0.47
2.7
2.4
u/ml
945.0
659.0
0.78
128
645
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
5
48
0.59
0.47
1.0
1.0
—
—
—
0
0
(40762814) Titanium [Mass/volume] in Blood
34
157
1.22
0.47
2.4
2.3
ug/l
2.9
4.4
1.32
16
60
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
109
553
1.11
0.46
1.3
1.8
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
431
2308
1.05
0.46
1.2
1.2
—
—
—
0
0
(4268621)
243
1279
1.07
0.46
2.4
2.2
—
—
—
0
0
(3013945) Hepatitis B virus e Ab [Presence] in Serum
14
57
1.38
0.45
1.9
1.4
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
8
30
1.50
0.44
1.4
1.1
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
107
666
0.90
0.44
1.6
1.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
22
156
0.79
0.44
18.5
7.3
—
—
—
0
0
(3003531) Amoxicillin IgE Ab [Units/volume] in Serum
5
17
1.66
0.44
1.0
1.0
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
5
17
1.66
0.44
1.0
1.0
—
—
—
0
0
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
10
80
0.70
0.44
1.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
19
137
0.78
0.43
1.1
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
54
263
1.16
0.43
1.2
1.1
—
—
—
0
0
(4015189)
50
242
1.16
0.43
2.2
2.7
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
9
0.00
0.43
0.0
1.2
—
64.0
—
0
9
(3014345) clomiPRAMINE [Moles/volume] in Serum or Plasma
0
9
0.00
0.43
0.0
2.7
—
392.1
—
0
9
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
202
1060
1.07
0.43
1.5
1.6
%
45.0
34.5
3.09
126
622
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
12
48
1.41
0.43
1.8
1.7
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
8
32
1.41
0.42
1.1
1.3
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
8
32
1.41
0.42
1.0
1.1
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
143
740
1.09
0.42
1.6
1.5
umol/l
60.0
63.8
—
8
70
(3022670) pH of Venous cord blood
0
10
0.00
0.42
0.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
861
4695
1.03
0.42
1.8
1.9
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
30
139
1.22
0.41
2.7
2.4
u/field
0.5
0.9
1.58
30
139
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
181
948
1.08
0.41
1.3
1.2
titre
146.8
187.1
0.40
31
168
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
59
291
1.14
0.41
1.3
1.3
nmol/l
134.8
121.3
0.31
44
209
(3024471) HLA-A [Type]
55
270
1.15
0.41
1.0
1.0
—
—
—
0
0
(3007919) Fasciola sp Ab [Titer] in Serum
5
19
1.48
0.40
1.0
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
94
478
1.11
0.40
1.2
1.2
nmol/l
59.8
59.9
0.01
94
471
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
91
462
1.11
0.40
1.1
1.1
ng/l
196.4
489.1
0.38
16
103
(3005082) Progesterone [Moles/volume] in Serum or Plasma
120
738
0.92
0.40
1.3
1.3
nmol/l
30.1
30.8
0.10
111
645
(3005011) Chlamydia sp Ab [Titer] in Serum
31
209
0.84
0.40
1.6
1.6
—
—
—
0
0
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
180
944
1.07
0.40
1.3
1.2
titre
314.0
120.3
—
5
29
(3036525) Urea [Moles/time] in 24 hour Urine
9
36
1.41
0.40
1.6
2.2
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
81
409
1.12
0.40
1.1
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
206
1086
1.07
0.39
2.5
2.6
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
362
1942
1.05
0.39
1.2
1.2
u/ml
4.8
3.7
0.67
141
809
(3011544) Albumin [Mass/volume] in Pleural fluid
9
37
1.37
0.39
1.3
1.1
g/l
19.8
15.1
—
9
29
(44806071)
28
190
0.83
0.39
1.1
1.1
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
8
64
0.70
0.38
1.1
1.3
—
—
—
0
0
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
13
54
1.36
0.38
1.0
1.1
mg/l
0.0
0.0
0.69
13
46
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
28
130
1.21
0.38
1.0
1.0
u/ml
0.6
0.0
0.44
13
73
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
8
65
0.69
0.38
1.0
1.2
ug/g
114.6
152.0
—
8
53
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
63
314
1.13
0.38
1.0
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
9
38
1.33
0.38
2.8
3.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
56
277
1.14
0.38
1.6
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
20
140
0.80
0.37
1.1
1.0
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
553
3000
1.04
0.37
1.3
1.3
mg/l
523.0
488.0
0.42
529
2859
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
12
90
0.75
0.37
1.1
1.0
u/ml
5.7
12.8
—
7
77
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
30
141
1.20
0.37
1.2
1.2
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
69
347
1.12
0.37
4.5
4.2
mg/l
2915.0
519.3
0.39
47
242
(3004616) Nuclear Ab [Presence] in Serum
338
1814
1.05
0.37
1.4
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
580
3151
1.04
0.37
1.2
1.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
17
121
0.79
0.36
1.3
2.2
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
6
24
1.41
0.35
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
128
779
0.93
0.35
1.2
1.1
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
64
322
1.12
0.35
1.3
1.4
%
40.3
49.6
1.11
57
276
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
29
137
1.19
0.35
6.5
4.7
ug/min
43.7
34.3
0.26
23
90
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
40
195
1.16
0.34
1.5
1.7
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
792
4334
1.03
0.34
1.6
1.8
g/l
1.2
1.2
2.10
752
4117
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
404
2184
1.04
0.34
1.1
1.1
u/ml
3.2
2.7
0.30
190
1126
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
76
388
1.10
0.33
2.0
2.1
ug/min
46.7
28.7
0.33
12
71
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
86
442
1.10
0.33
1.2
1.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
41
264
0.87
0.33
1.1
1.2
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
111
676
0.92
0.32
1.2
1.4
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
41
1.37
0.32
1.0
1.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
137
827
0.93
0.32
2.2
1.7
mmol/l
6.9
6.5
0.80
91
583
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
113
589
1.08
0.32
1.1
1.1
—
—
—
0
0
(4133840)
44
281
0.88
0.31
1.2
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
120
727
0.93
0.31
1.2
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
20
92
1.22
0.31
2.0
2.1
—
—
—
0
0
(40762887) Creatinine [Moles/volume] in Blood
7
30
1.31
0.31
1.3
1.2
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
488
2655
1.04
0.31
1.2
1.2
mmol/l
3.6
3.7
0.29
460
2481
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
139
732
1.07
0.31
1.1
1.1
u/ml
9.8
6.9
0.48
22
133
(44806420)
46
229
1.13
0.30
2.1
2.3
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
136
716
1.07
0.30
1.4
1.3
umol/l
3.4
4.5
3.69
126
657
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
189
1006
1.06
0.30
1.5
1.6
—
—
—
0
0
(4027681)
159
842
1.06
0.30
1.3
1.2
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
317
1711
1.04
0.30
1.3
1.4
mmol/l
59.1
62.9
0.94
256
1354
(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood
16
72
1.25
0.30
1.0
1.3
ml/s/173m2
1.2
2.7
—
10
39
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
2599
14840
0.99
0.29
1.6
1.8
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
11
80
0.77
0.29
1.0
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
2043
11334
1.02
0.29
1.2
1.2
iu/ml
137.9
153.3
1.03
773
4656
(3041806) Other cells [#/volume] in Blood by Manual count
35
225
0.88
0.28
1.7
1.5
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
33
213
0.87
0.28
1.2
1.3
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
27
130
1.17
0.28
1.1
1.2
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
164
977
0.95
0.27
1.0
1.1
u/ml
0.5
3.5
0.73
46
244
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
16
110
0.82
0.27
1.1
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
178
950
1.06
0.27
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
56
285
1.11
0.27
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
112
589
1.07
0.27
1.2
1.2
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
25
164
0.86
0.27
1.0
1.0
u/ml
0.1
0.2
0.67
14
97
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
5
43
0.65
0.27
1.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
12
85
0.80
0.26
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
114
601
1.07
0.26
1.1
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
58
297
1.10
0.26
1.0
1.0
mg/g
8.1
5.5
1.09
50
277
(3034988) Calcium [Moles/volume] in Capillary blood
36
179
1.13
0.25
2.5
1.8
mmol/l
1.2
1.2
0.83
36
170
(3008116) Ketones [Moles/volume] in Urine by Test strip
30
193
0.88
0.25
1.2
1.4
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
10
43
1.31
0.25
1.0
1.0
—
—
—
0
0
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
207
1113
1.05
0.25
1.3
1.2
u/ml
76.8
63.4
0.26
13
63
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
120
719
0.94
0.25
1.1
1.2
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
159
849
1.06
0.25
1.1
1.1
ratio
1.1
1.1
0.24
51
287
(3008295) Osmolality of Serum or Plasma
179
959
1.05
0.25
1.4
1.5
mosm/kgh2o
279.1
278.1
0.28
142
731
(3009677) Dengue virus Ab [Presence] in Serum
6
48
0.70
0.25
1.0
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
65
336
1.09
0.24
1.3
1.6
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
36
180
1.13
0.24
1.2
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
207
1115
1.05
0.24
1.3
1.2
u/ml
48.5
49.0
0.01
12
93
(3045177) Copper [Moles/volume] in Urine
5
21
1.34
0.24
1.4
1.0
umol/l
1.1
0.2
—
5
10
(3009871) Measles virus Ab [Titer] in Serum
84
508
0.93
0.23
1.8
1.7
—
—
—
0
0
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
43
218
1.11
0.23
1.1
1.1
u/ml
0.7
0.2
0.35
25
135
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
65
397
0.92
0.23
2.3
2.4
au/ml
176.4
166.5
0.05
11
48
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
81
490
0.93
0.23
1.0
1.0
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
278
1624
0.96
0.23
1.5
1.6
iu/ml
45.9
36.9
0.19
11
78
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
92
485
1.07
0.22
1.8
2.0
umol/l
146.9
134.6
0.15
43
267
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
6
0.00
0.22
0.0
1.0
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
128
683
1.06
0.22
1.2
1.2
titre
44.3
50.3
—
7
60
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
8
0.00
0.21
0.0
1.0
—
19.6
—
0
8
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
364
1990
1.03
0.21
1.2
1.2
u/ml
3.1
3.4
0.08
101
670
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
76
399
1.07
0.21
2.1
2.3
umol/l
51.9
52.2
0.03
57
322
(3038026) Centromere Ab [Units/volume] in Serum
211
1142
1.04
0.21
1.3
1.2
u/ml
40.4
60.9
—
9
54
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
6
27
1.25
0.20
1.0
1.0
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
20
130
0.87
0.20
1.0
1.0
u/ml
0.3
2.1
0.54
12
90
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
12
55
1.23
0.20
1.0
1.3
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
57
297
1.08
0.19
1.1
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
50
259
1.09
0.19
3.8
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
50
259
1.09
0.19
3.8
2.7
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
54
281
1.08
0.19
1.1
1.1
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
7
32
1.23
0.19
1.0
1.1
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
20
129
0.87
0.19
1.0
1.0
u/ml
0.0
0.5
0.89
13
86
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
76
456
0.94
0.19
1.7
1.8
mg/l
8.8
9.7
0.56
61
364
(3036071) Salmonella sp Ab [Titer] in Serum
77
407
1.07
0.19
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
1558
8885
0.99
0.18
1.5
1.4
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
119
704
0.95
0.18
1.0
1.0
ng/l
39.2
47.2
0.83
90
494
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
768
4249
1.02
0.18
1.7
1.8
g/l
0.2
0.2
0.87
726
4030
(3044009) aPTT.lupus sensitive (LA screen)
18
117
0.87
0.18
1.2
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
29
182
0.90
0.18
5.0
4.9
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
110
652
0.95
0.18
2.2
2.3
ml
710.5
617.6
1.31
74
492
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
16
105
0.86
0.18
1.2
1.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
24
152
0.89
0.18
1.1
1.1
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
74
392
1.06
0.17
3.6
2.4
mmol/l
9.2
9.1
0.14
54
280
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
40
0.70
0.17
2.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
164
960
0.96
0.17
1.4
1.3
nmol/l
1.1
1.3
0.99
135
775
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
81
431
1.06
0.17
1.1
1.1
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
13
86
0.85
0.16
1.4
2.1
umol/l
46.3
49.7
0.26
13
86
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
72
430
0.94
0.16
2.8
2.9
mg/l
7.9
7.8
0.04
52
336
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
736
4213
0.98
0.16
1.1
1.1
u/ml
3.0
5.4
1.38
96
566
(3019174) dRVVT (LA screen)
19
121
0.88
0.15
1.2
1.2
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
119
699
0.96
0.15
1.0
1.0
ng/l
784.0
749.0
0.40
86
483
(42529582) MDA5 Ab [Presence] in Serum by Line blot
59
312
1.07
0.15
1.1
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
59
312
1.07
0.15
1.1
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
59
312
1.07
0.15
1.1
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
59
312
1.07
0.15
1.1
1.2
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
7
49
0.80
0.15
1.6
2.8
—
20.5
—
0
13
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
41
249
0.93
0.15
1.2
1.1
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
247
1354
1.03
0.14
1.1
1.1
%
93.8
94.9
0.26
233
1266
(3019768) Coxiella burnetii Ab [Presence] in Serum
8
54
0.83
0.14
1.0
1.1
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
76
407
1.05
0.14
1.0
1.1
u/ml
2.8
1.0
0.37
36
211
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
36
219
0.93
0.13
1.1
1.0
u/ml
0.2
0.5
0.28
24
149
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
112
606
1.04
0.13
1.9
1.7
u/field
2.1
2.1
0.00
86
409
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
671
3724
1.02
0.13
1.6
1.6
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
23
143
0.91
0.13
1.1
1.1
umol/24h
1.6
1.6
0.13
23
143
(3042733) HLA Ab [Presence] in Serum
55
292
1.06
0.13
5.3
5.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
95
513
1.04
0.13
1.3
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
137
798
0.97
0.12
1.4
1.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
122
663
1.04
0.12
1.1
1.2
u/ml
26.9
7.1
0.56
11
57
(3006653) Thiamine [Moles/volume] in Blood
109
591
1.04
0.12
1.4
1.5
nmol/l
137.6
132.2
0.68
109
591
(43055514) Macroprolactin [Presence] in Serum or Plasma
57
339
0.95
0.12
1.2
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
192
1111
0.97
0.12
2.4
2.5
—
—
—
0
0
(3002621) Streptococcal DNAse B [Units/volume] in Serum
14
69
1.14
0.12
1.1
1.0
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
52
277
1.06
0.11
1.1
1.1
—
—
—
0
0
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
25
129
1.09
0.11
1.0
1.0
u/ml
0.0
0.0
0.55
12
71
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
29
151
1.08
0.11
1.2
1.2
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
48
286
0.95
0.11
1.7
2.0
e6/l
165.9
171.5
0.05
29
169
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
967
5392
1.01
0.11
1.7
1.7
mg/l
3.2
3.3
0.27
693
3843
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
968
5508
0.99
0.11
1.8
2.0
u/l
5409.2
4462.3
0.40
316
2154
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
2275
12895
0.99
0.11
1.8
1.6
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
26
135
1.08
0.10
1.2
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
194
1067
1.02
0.10
1.3
1.2
u/ml
2.6
8.7
—
10
92
(3014891) Appearance of Pleural fluid
11
71
0.87
0.10
1.8
1.6
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
23
119
1.09
0.10
1.0
1.0
u/ml
0.1
0.8
0.89
12
63
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
5
25
1.13
0.10
1.0
1.1
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
150
823
1.03
0.10
1.8
1.9
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
31
163
1.07
0.10
1.5
1.5
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
34
204
0.94
0.10
1.6
2.7
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
124
719
0.97
0.10
1.3
1.6
promille
1.2
1.3
0.17
97
545
(3029612) Listeria sp Ab [Titer] in Serum
5
26
1.08
0.10
1.0
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
107
584
1.03
0.09
1.1
1.1
miu/ml
1641.7
1519.2
0.46
107
584
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
119
690
0.97
0.09
1.0
1.0
ng/l
658.7
333.0
0.57
90
495
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
5
27
1.04
0.09
4.2
5.0
mmol/l
0.2
0.2
—
5
27
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
480
2669
1.01
0.09
1.3
1.3
e6/l
25.5
32.6
0.36
377
2090
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
13
82
0.89
0.09
1.1
1.0
u/ml
0.2
0.4
—
5
51
(3020356) Listeria sp identified in Specimen by Organism specific culture
13
82
0.89
0.09
1.0
1.1
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
6
30
1.13
0.09
1.3
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
285
1579
1.02
0.09
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
1275
7131
1.01
0.09
1.5
1.5
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
6
32
1.06
0.09
1.0
1.1
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
146
803
1.02
0.08
1.3
1.5
u/ml
16.4
23.3
1.70
25
166
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
77
419
1.04
0.08
1.3
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
1004
5612
1.01
0.08
1.1
1.1
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
6
41
0.82
0.08
1.2
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
65
353
1.04
0.08
1.1
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
4640
26216
1.00
0.07
4.2
4.1
kg/l
1.0
1.0
0.87
717
4003
(44816559) Phosphatidylethanol [Mass/volume] in Blood
355
1974
1.01
0.07
1.2
1.3
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
96
526
1.03
0.07
1.5
1.4
pmol/l
14.3
14.3
0.03
76
445
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
8
44
1.02
0.07
1.1
1.3
%
1.7
2.3
—
8
44
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
592
3365
0.99
0.07
1.3
1.3
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
11
69
0.90
0.07
1.5
1.2
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
9
57
0.89
0.06
1.0
1.1
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
9
57
0.89
0.06
1.0
1.0
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
479
2673
1.01
0.06
1.3
1.4
e6/l
1583.5
1856.9
0.14
397
2197
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
75
434
0.97
0.06
4.5
4.2
u/ml
311.7
1689.9
—
9
50
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
13
80
0.92
0.06
1.2
1.1
u/l
9.9
11.8
0.17
13
80
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
11
68
0.91
0.05
1.0
1.0
—
27.8
—
0
14
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
689
3904
0.99
0.04
1.6
1.6
iu/ml
0.1
5.3
0.61
138
757
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
27
159
0.96
0.04
2.2
1.3
%
51.4
50.5
0.03
14
91
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
210
1196
0.99
0.04
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
210
1196
0.99
0.04
1.1
1.2
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
35
190
1.04
0.04
1.4
1.2
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
13
79
0.93
0.04
1.1
1.1
—
—
—
0
0
(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum
16
96
0.94
0.04
1.0
1.0
u/ml
0.0
0.5
—
10
70
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
54
312
0.97
0.04
1.0
1.1
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
31
168
1.04
0.04
1.2
1.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
164
913
1.01
0.03
1.0
1.0
—
—
—
0
0
(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma
68
375
1.02
0.03
1.6
1.6
au/ml
123.4
144.0
—
8
52
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
68
375
1.02
0.03
1.3
1.2
%
42.5
19.3
1.33
14
69
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
55
317
0.98
0.03
1.1
1.2
—
—
—
0
0
(4034850)
749
4233
1.00
0.02
7.7
8.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
67
371
1.02
0.02
1.1
1.1
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
28
163
0.97
0.02
1.7
1.7
mg/l
1.2
1.6
1.43
23
135
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
211
1197
0.99
0.02
1.1
1.2
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
104
579
1.01
0.02
1.5
1.5
%
3.9
4.3
0.08
18
116
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
53
293
1.02
0.02
1.2
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
138
784
0.99
0.02
1.1
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
208
1179
0.99
0.02
1.1
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
219
1227
1.01
0.01
1.3
1.5
—
—
—
0
0
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
14
83
0.95
0.01
1.1
1.1
u/ml
1.4
3.8
—
8
62
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
209
1182
1.00
0.01
1.1
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
62
353
0.99
0.00
1.6
2.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
299
1688
1.00
0.00
1.5
1.5
—
—
—
0
0
(3001729) Color of Synovial fluid
15
85
0.99
0.00
1.9
1.7
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
26
145
1.01
0.00
2.6
2.3
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
38
213
1.00
0.00
1.1
1.0
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
51
284
1.01
0.00
1.1
1.1
umol/24h
0.5
0.6
0.74
23
143
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
36
203
1.00
0.00
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
36
203
1.00
0.00
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
36
203
1.00
0.00
1.0
1.1
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
24
132
1.02
0.00
1.1
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
116
652
1.00
0.00
1.2
1.2
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
167
942
1.00
0.00
1.0
1.0
u/ml
0.9
1.7
0.48
43
192
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
101
568
1.00
0.00
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
209
1180
1.00
0.00
1.1
1.2
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
364
2051
1.00
0.00
2.3
2.4
ug/min
72.6
63.2
0.18
204
1182
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
31
174
1.00
0.00
1.9
1.6
mmol/l
1.2
1.2
1.39
31
164
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
31
174
1.00
0.00
1.5
1.6
nmol/l
480008.8
238854.4
0.30
25
139
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
25
139
1.01
0.00
1.2
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
381
2145
1.00
0.00
1.5
1.5
—
—
—
0
0
(3000492) Spirometry study
2109
11883
1.00
0.00
1.4
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
48
272
0.99
0.00
1.2
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
181
1020
1.00
0.00
1.2
1.2
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
12
65
1.04
0.00
1.2
1.0
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
28
157
1.00
0.00
1.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
291
1641
1.00
0.00
1.1
1.1
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
19
108
0.99
0.00
1.1
1.1
nmol/l
10.8
13.4
—
6
26
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
64
358
1.01
0.00
4.2
4.1
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
13
74
0.99
0.00
1.8
2.2
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
117
661
1.00
0.00
1.1
1.2
mmol/l
34.1
31.9
0.47
97
548
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
54
303
1.00
0.00
1.1
1.1
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
15
86
0.98
0.00
1.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
5
32
0.88
0.00
1.2
1.0
—
—
—
0
0
(3002568) Complement factor B [Mass/volume] in Serum or Plasma
7
41
0.96
0.00
1.1
1.0
g/l
0.2
0.2
—
7
31
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
5
28
1.01
0.00
1.2
1.0
—
—
—
0
0
(3042628) Porphyrins [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis
8
48
0.94
0.00
1.3
1.1
u/l
357.5
390.7
—
8
42
(3016072) Theophylline [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
9
56
0.91
0.00
1.0
1.1
—
—
—
0
0
(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014171) Thiocyanate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
190.4
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_LEIOMYOMA_UTERI_EXALLC – Leiomyoma of uterus
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).